clopidogrel has been researched along with Complication, Postoperative in 288 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (0.35) | 18.2507 |
2000's | 79 (27.43) | 29.6817 |
2010's | 187 (64.93) | 24.3611 |
2020's | 21 (7.29) | 2.80 |
Authors | Studies |
---|---|
Amano, T; Ikari, Y; Inohara, T; Ishii, H; Kohsaka, S; Nishida, H; Noma, S; Shimoji, K; Tanaka, N; Ueno, K; Yamaji, K; Yashima, F | 1 |
Kakkos, SK; Twine, CP; Wong, KHF; Zlatanovic, P | 1 |
Bernasek, TL; Engel, CC; Gill, MK; Maxfield, DG | 1 |
Intini, A; Sahadevan, J; Tsushima, T | 1 |
Abe, M; Ando, K; Doi, M; Domei, T; Furukawa, Y; Hanaoka, KI; Hata, Y; Hibi, K; Ikari, Y; Kadota, K; Kawai, K; Kimura, T; Kozuma, K; Morimoto, T; Morino, Y; Nakagawa, Y; Nakao, K; Nanasato, M; Natsuaki, M; Noda, T; Ohya, M; Okayama, H; Sakamoto, H; Seino, Y; Shiomi, H; Suematsu, N; Suwa, S; Tada, T; Takagi, K; Takamisawa, I; Tanabe, K; Toyota, T; Watanabe, H; Yagi, M; Yokomatsu, T | 1 |
Davis, BH; DeFrank, G; Harada, S; Limdi, NA | 1 |
Bolognese, L; Cantor, WJ; Cequier, Á; Chettibi, M; Collet, JP; Diallo, A; Ecollan, P; Fabris, E; Goodman, SG; Hamm, CW; Hammett, CJ; Hermanides, RS; Huber, K; Janzon, M; Lapostolle, F; Lassen, JF; Merkely, B; Montalescot, G; Silvain, J; Storey, RF; Tavenier, AH; Ten Berg, JM; van 't Hof, AWJ; Vicaut, E; Willems, FF; Zeymer, U | 1 |
Abu-Assi, E; Alexopoulos, D; Ariza-Solé, A; Autelli, M; Biolè, C; Biondi-Zoccai, G; Blanco, PF; Boccuzzi, G; Bongiovanni, F; Cequier, A; Cerrato, E; Conrotto, F; Correia, L; D'Ascenzo, F; De Ferrari, GM; Dominguez-Rodriguez, A; Durante, A; Fabrizio, U; Fernández, MC; Fujii, T; Gaido, F; Gallo, D; Garay, A; Gili, S; González-Juanatey, JR; Grosso, A; Henriques, JPS; Huczek, Z; Iñiguez-Romo, A; Kawaji, T; Kawashiri, MA; Kinnaird, T; Liebetrau, C; Magnani, G; Manzano-Fernández, S; Montabone, A; Morbiducci, U; Nie, SP; Nuñez-Gil, I; Omedè, P; Paz, RC; Pousa, IM; Quadri, G; Queija, BC; Raposeiras-Roubin, S; Rettegno, S; Rognoni, A; Song, X; Stone, GW; Taha, S; Templin, C; Valdés, M; Velicki, L; Wilton, SB; Xanthopoulou, I | 1 |
Affeldt, J; Bemme, S; Bertelmann, T; Callizo, J; Feltgen, N; Hoerauf, H; Khattab, MH; Lauermann, P; Pfeiffer, S; Striebe, NA | 1 |
Brennan, MM; Corliss, BM; Fox, WC; Freedman, R; Harris, NS; Hoh, BL; Nerva, JD; Polifka, AJ; Smith, J | 1 |
Jiang, J; Li, Q; Qian, Y; Shen, X; Su, T; Wang, S; Wang, Z; Yan, K; Zhang, P; Zhang, Y | 1 |
De Luca, G; Khedi, E; Suryapranata, H; Verdoia, M | 1 |
Murphy, SA; O'Donoghue, ML; Sabatine, MS | 1 |
Abraham, NS; Herrin, J; Inselman, J; Ngufor, C; Noseworthy, PA; Sangaralingham, LR; Shah, ND; Yang, EH; Yao, X | 1 |
Im, C; Oh, TK; Song, IA | 1 |
Agati, LB; Bernardi, WH; Biagioni, RB; Caffaro, RA; Casella, IB; Comerota, AJ; de Freitas Soares, BL; Fidelis, RJR; Fioranelli, A; Flumignan, RLG; Joviliano, EE; Junior, VC; Lopes, RD; Ramacciotti, E; Sacilotto, R; Sobreira, ML; Van Bellen, B; Wolosker, N | 1 |
Ai, H; Liu, R; Zhang, YJ; Zhao, XD; Zheng, W | 1 |
Alsanjari, O; Hildick-Smith, D; Parker, J; Thomson, C; Trivedi, U | 1 |
Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J; Wintzer-Wehekind, J | 1 |
Avram, R; Bailey, K; Byrne, J; Farkouh, ME; Geller, N; Goodman, SG; Iturriaga, E; Lennon, RJ; Marcus, GM; Murthy, V; Olgin, JE; Pereira, NL; Pletcher, MJ; Rihal, C; Rosenberg, Y; So, DY | 1 |
Alvarez-Covarrubias, H; Cassese, S; Joner, M; Kastrati, A; Kufner, S; Lahmann, AL; Mayr, NP; Ndrepepa, G; Pellegrini, C; Rai, H; Rheude, T; Schunkert, H; Xhepa, E | 1 |
Biederko, R; Borodetsky, V; Horev, A; Ifergane, G; Shelef, I; Star, M; Zlotnik, Y; Zvenigorodsky, V | 1 |
Alfredsson, J; Desta, L; Erlinge, D; Hagström, E; Jernberg, T; Lindahl, B; Mellbin, L; Nilsson, J; Omerovic, E; Szummer, KE; Träff, E; Venetsanos, D; Zwackman, S | 1 |
Cui, JG; Huang, XH; Liu, G; Lu, J; Wu, X; Zhao, XY; Zheng, XX | 1 |
Altman, DG; Benedetto, U; Flather, M; Gerry, S; Gray, A; Lees, B; Taggart, DP | 1 |
Abnousi, F; Bhatt, DL; Deliargyris, EN; Desai, M; Ding, VY; Généreux, P; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; Sundaram, V; White, HD; Yang, L; Yong, CM | 1 |
Ait Hamou, Z; Baillard, C; Chilot, F; Eyraud, V; Pailleret, C; Rosencher, N; Samama, CM | 1 |
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; Vaduganathan, M; White, HD | 1 |
Chen, X; Liu, Z; Ren, J; Sun, T; Wang, J; Wang, X; Zhang, J | 1 |
Agrawal, V; Almahmoud, K; Burlew, CC; Cahill, A; Campion, EM; Dissanaike, S; Foley, N; Frazee, R; Hartline, C; Jackson, T; Kim, D; Michaels, D; Nelson, P; Olatubosun, O; Pearcy, C; Regner, J; Spence, L; Stewart, C; Todd, SR; Truitt, MS | 1 |
Antonoff, MB; Atay, SM; Correa, AM; Hofstetter, WL; Mehran, RJ; Rice, DC; Roth, JA; Sepesi, B; Swisher, SG; Vaporciyan, AA; Walsh, G | 1 |
Albaladejo, P; Kamphuisen, P; Llau, JV | 1 |
Becher, PM; Blankenberg, S; Fluschnik, N; Schnabel, R; Westermann, D | 1 |
Cognetti, DM; Curry, JM; Luginbuhl, A; Shumrick, C; Tassone, P; Topf, MC; Vo, A | 1 |
Hirono, S; Ikegami, R; Minamino, T; Ozaki, K; Ozawa, T; Suda, M; Takano, T; Tanaka, K; Wakasugi, T; Yanagawa, T | 1 |
Ahn, SG; Cho, YH; Choi, W; Garg, S; Gwon, H; Hong, MK; Hong, SJ; Jang, Y; Joo, HJ; Kang, WC; Kim, SY; Kim, W; Kim, YH; Lim, DS; Lim, YH; Park, JH; Park, JY; Shin, W; Yoon, J | 1 |
Consolo, F; D'Angelo, A; Della Valle, P; Pappalardo, F; Pozzi, L; Sferrazza, G; Slepian, MJ | 1 |
Almassi, GH; Bakaeen, FG; Bishawi, M; Carr, BM; Collins, J; Ebrahimi, R; Grover, FL; Gupta, S; Hattler, B; Quin, JA; Shroyer, ALW; Wagner, TH | 1 |
Aguilar Perez, M; Bäzner, H; Bhogal, P; Ganslandt, O; Henkes, H | 1 |
Banerjee, K; Garg, A; Goel, S; Hollander, G; Kapadia, S; Krishnaswamy, A; Mick, S; Raheja, H; Shani, J; White, J | 1 |
Atkins, D; Berenbom, LD; Cunnane, R; Dendi, R; Emert, MP; Lakkireddy, DR; Lavu, M; Parikh, V; Pimentel, R; Reddy, YM; Sheldon, SH | 1 |
Morita, A; Tamaki, T | 1 |
Adeeb, N; Cognard, C; Dmytriw, AA; Foreman, PM; Griessenauer, CJ; Harrigan, MR; Krings, T; Kumar, A; Levy, EI; Limbucci, N; Mangiafico, S; Marotta, TR; Matouk, CC; Michelozzi, C; Ogilvy, CS; Pereira, VM; Renieri, L; Shakir, HJ; Shallwani, H; Siddiqui, AH; Thomas, AJ | 1 |
Hirata, KI; Kijima, Y; Kozuki, A; Masano, T; Nagoshi, R; Otake, H; Shibata, H; Shinke, T; Shite, J; Takeshige, R; Tsukiyama, Y; Yanaka, KI | 1 |
Alexander, JH; Lopes, RD; Newby, LK; Newman, MF; Smith, PK; Wang, A; Wojdyla, D; Wu, A | 1 |
Jiriaee, L; Jiriaee, Z; Rahmani, R; Shafiee, A; Zand Parsa, AF | 1 |
Accola, K; Armitage, J; Askew, J; Azar, H; Copeland, J; Douville, EC; Duncan, D; Ely, J; Fermin, L; Gerdisch, M; Graeve, A; Hagberg, R; Hughes, GC; Jamieson, WRE; Kapoor, D; Kong, B; Landvater, L; Levy, P; Martin, T; McGrath, M; Meyer, S; Nichols, D; Puskas, JD; Quinn, R; Rhenman, B; Trotter, T; Wait, M; Yanagawa, B; Ye, J | 1 |
Alper, AT; Barutca, H; Bora Şişman, S; Bozbeyoğlu, E; Çakıllı, Y; Çinier, G; Güzelburç, Ö; Şahin, S; Tekkeşin, Aİ; Velibey, Y; Yıldırımtürk, Ö | 1 |
Li, X; Lv, Q; Wang, Q; Wang, Z; Xu, Q | 1 |
Aylward, PE; Bhatt, DL; Fox, KAA; Gurbel, PA; Hamm, C; Hinohara, TT; Huber, K; Neely, ML; Ohman, EM; Roe, MT; White, HD; Wiviott, SD | 1 |
Bortone, AS; Cecere, A; Ciccone, MM; D'Alessandro, P; Favale, S; Fumarola, F; Giordano, A; Guaricci, AI; Marchese, A; Pepe, M | 1 |
Cho, WS; Cho, YD; Ha, EJ; Han, MH; Kang, HS; Kim, JE; Kim, KH; Lee, J | 1 |
Bhatt, DL; Deliargyris, EN; Généreux, P; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD | 1 |
Hoppe, UC; Jung, C; Lauten, A; Lichtenauer, M; Navarese, EP; Wernly, B | 1 |
Bhattacharya, J; Chang, M; Kaltenbach, T; Limketkai, BN; Lin, J; Oliver, M; Soetikno, R; Yu, JX | 1 |
Hein, M; Hochholzer, W; Hromek, J; Kille, A; Neumann, FJ; Nührenberg, TG; Ruile, P; Stratz, C; Trenk, D | 1 |
Anthopoulos, P; Chandrasekhar, J; Claessen, B; Colombo, A; Dangas, G; Deliargyris, EN; Hengstenberg, C; Hildick-Smith, D; Hink, HU; Kupatt, C; Lefèvre, T; Mehran, R; Nijenhuis, VJ; Sartori, S; Ten Berg, JM; Tron, C; Van Belle, E; Windecker, S | 1 |
Ahn, KT; Chae, SC; Cho, MC; Choi, SW; Choi, UL; Gwon, HC; Jeong, JO; Jeong, MH; Jin, SA; Kim, CJ; Kim, HS; Kim, JH; Kim, YJ; Lee, JH; Seong, IW; Seong, SW | 1 |
Araszkiewicz, A; Grajek, S; Grygier, M; Hengstenberg, C; Komosa, A; Krasiński, Z; Lesiak, M; Mitkowski, P; Mularek-Kubzdela, T; Olasińska-Wiśniewska, A; Pyda, M; Siller-Matula, JM; Siniawski, A; Skorupski, W | 1 |
Gleason, TG; Kilic, A; Navid, F; Seese, L; Sultan, I; Wang, Y | 1 |
Audrone, V; Jurgaityte, J; Kupstyte-Kristapone, N; Lesauskaite, V; Norvilaite, R; Skipskis, V; Stuoka, M; Tamakauskas, V; Tatarunas, V | 1 |
Alapati, V; Benson, MM; Brener, SJ; Chan, D; Cunn, G; Khan, S; Kutkut, I; Narayanan, CA; O'Laughlin, JP; Sacchi, TJ | 1 |
Dantzler, D; Lynch, DR; Robbins, M; Zhao, D | 1 |
Chang, JP; Chen, HC; Chen, MC; Chen, YL; Guo, BF; Lin, YS; Pan, KL; Tsai, TH | 1 |
Altarabsheh, SE; Boilson, BA; Deo, SV; Dunlay, SM; Erwin, PJ; Joyce, LD; Park, SJ; Shah, IK | 1 |
Davies, AH; Jenkins, IH; Mehta, A; Thapar, A | 1 |
Golan, S; Kurtz, S; Levkovitch-Verbin, H; Shemesh, G | 1 |
Hossain, FS; Koch, L; Rambani, R; Ribee, H | 1 |
Bazargan, A; Douglas, G; McKenzie, JL | 1 |
Ağırbaşlı, M; Tanrıkulu, A | 1 |
Christensen, CB; Gislason, GH; Hansen, ML; Kristensen, SL; Køber, L; Lamberts, M; Lip, GY; Mikkelsen, A; Olesen, JB; Schjerning Olsen, AM; Torp-Pedersen, C | 1 |
Avanzas, P; Callejo, F; Hernández-Vaquero, D; Llosa, JC; López, J; Morales, C | 1 |
Eckl, S; Ensminger, SM; Koch, N; Preidl, RH; Ramsperger-Gleixner, M; Spriewald, BM; Weyand, M | 1 |
Acosta, J; Benezet, J; Cubero Gómez, JM; Díaz DE LA Llera, LS; Fernández-Cisnal, A; Parejo, J; Rangel, D; Zafra, F | 1 |
Bigalke, B; Gawaz, M; Geisler, T; Karathanos, A; Meissner, M; Müller, II; Müller, KA; Schaeffeler, E; Schwab, M; Stellos, K; Stimpfle, F; Tavlaki, E | 1 |
Biscaglia, S; Campo, G; Ferrari, R; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P | 1 |
Brennan, T; Canestaro, WJ; Chaplin, D; Choudhry, NK; Desai, NR; Kyrychenko, P; Martell, LA; Matlin, OS | 1 |
Abramowicz, D; Benahmed, A; Broeders, N; Donckier, V; Ghisdal, L; Hoang, AD; Kianda, M; Le Moine, A; Lemy, A; Madhoun, P; Massart, A; Mikhalski, D; Racapé, J; Sadis, C; Wissing, M | 1 |
Biocina, B; Djuric, Z; Gasparovic, H; Kopjar, T; Petricevic, M; Svetina, L | 1 |
Gray, S; Keville, N; Murray, AM | 1 |
Akioka, N; Hayakawa, Y; Kashiwazaki, D; Kuroda, S; Kuwayama, N | 1 |
Agrawal, N; Parekh, P; Vasavada, A; Vinchurkar, M | 1 |
Abbassi-Ghadi, N; James, K; Kasivisvanathan, R; Kumar, S; Mackenzie, H; Mallett, SV; Thompson, K | 1 |
Alexander, KP; Bagai, A; Bhatt, DL; Cheema, AN; Curtis, JP; Granger, CB; Gurm, HS; McNamara, RL; Peterson, ED; Roe, MT; Saucedo, JF; Shah, B; Wang, TY; Wang, Y | 1 |
Daels, FP; de la Rosette, JJ; Erkan, E; Gaizauskas, A; Melekos, M; Ozgok, Y; Rioja, J; Varshney, AK | 1 |
Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P | 1 |
Alexander, JH; Califf, RM; Englum, BR; Gibson, CM; Hager, R; Hess, CN; Kouchoukos, NT; Lopes, RD; Mack, MJ; Peterson, ED; Wojdyla, DM | 1 |
Fleisher, LA; Patel, PA | 1 |
Agabiti, N; Autore, C; Bauleo, L; Belleudi, V; Davoli, M; Di Martino, M; Fusco, D; Kirchmayer, U; Mayer, F; Perucci, CA; Pinnarelli, L; Ricci, R; Violini, R | 1 |
Ikeda, Y; Isshiki, T; Kimura, T; Kitagawa, K; Miyazaki, S; Nakamura, M; Nanto, S; Nishikawa, M; Ogawa, H; Saito, S; Takayama, M; Yokoi, H | 1 |
Abernathy, SW; Anderson, K; Frazee, RC; Jupiter, DC | 1 |
Armengaud, J; Barragan, P; Benamer, H; Berland, J; Blanchard, D; Boschat, J; Bressolette, E; Carrie, D; Cassat, C; Castellant, P; Cazaux, P; Champagnac, D; Darremont, O; Dauphin, R; Delarche, N; Druelles, P; Dupouy, P; Endresen, K; Furber, A; Gilard, M; Gommeaux, A; Hovasse, T; Jouve, B; Kermarrec, A; Kiss, RG; Le Breton, H; Levy, G; Lyuycx-Bore, A; Maillard, L; Majwal, T; Morice, MC; Noor, HA; Noryani, AAL; Ohlmann, P; Ormezzano, O; Paganelli, F; Sainsous, J; Schneeberger, M; Ungi, I; Wojcik, J | 1 |
Cohen, DJ; Galper, BZ; Garg, P; Mauri, L; Yeh, RW | 1 |
Airoldi, F; Briguori, C; Campo, G; Colangelo, S; de Cesare, N; Dellavalle, A; Ferlini, M; Gabriel, HM; Garbo, R; Liistro, F; McFadden, E; Meliga, E; Menozzi, A; Patialiakas, A; Roffi, M; Tebaldi, M; Testa, L; Thury, A; Tondi, S; Ungi, I; Valgimigli, M; Vranckx, P | 1 |
Kandzari, DE | 1 |
Farkouh, ME; Gandhi, S; Natarajan, MK; Schwalm, JD; Velianou, JL | 1 |
Bell, JJ; Crawford, RW; Ginsel, BL; Pulle, CR; Taher, A; Whitehouse, SL | 1 |
Bono, J; Nandi, S; Shubert, D | 1 |
Ajani, AE; Andrianopoulos, N; Brennan, A; Clark, DJ; Duffy, SJ; Eccleston, D; Farouque, O; Reid, C; Yudi, MB | 1 |
Généreux, P; Kirtane, AJ; Madhavan, MV; Mehran, R; Stone, GW; Witzenbichler, B; Xu, K | 1 |
Fletcher, J; Gruen, R; Koh, TL; Ong, WL; Royce, P | 1 |
Capranzano, P; Castiglioni, B | 1 |
Kioufis, S; Kokkou, E; Mourouzis, K; Oikonomou, E; Papavassiliou, AG; Siasos, G; Stone, PH; Tousoulis, D; Vavuranakis, M; Vlasis, K; Zaromitidou, M | 1 |
Gaist, D; García Rodríguez, LA; Hallas, J; Pottegård, A; Poulsen, FR | 1 |
Bulaeva, NI; Fortmann, S; Golukhova, EZ; Grigorian, MV; Ryabinina, MN; Serebruany, VL | 1 |
Alaraj, A; Aletich, V; Tesoro, E; Wong, P | 1 |
Brodie, BR; Garg, A; Kirtane, AJ; Maehara, A; Mehran, R; Metzger, DC; Neumann, FJ; Parvataneni, R; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B | 1 |
Brodie, BR; Cox, DA; Duffy, PL; Henry, TD; Kirtane, AJ; Maehara, A; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Parvataneni, R; Rinaldi, MJ; Smilowitz, NR; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K | 1 |
Kesavamoorthy, B; Virmani, R; Yahagi, K | 1 |
Chang, K; Choi, YS; Chung, WB; Chung, WS; Kim, HY; Kim, JY; Kwon, A; Lee, MY; Park, CS; Seung, KB | 1 |
Jiang, Y; Li, Y; Yang, H | 1 |
Carlson, ML; Driscoll, CL; Haynes, DS; Hunter, JB; Sweeney, AD; Tombers, NM; Wanna, GB | 1 |
Fu, Q; Huang, YJ; Zhang, N; Zhang, Q; Zhu, K | 1 |
Casutt, A; Koutsokera, A; Krueger, T; Lovis, A; Nicod, LP; Noetzli, J; Perentes, JY; Pons, M; Valenti, A | 1 |
Bonczek, S; Nanu, A; Purushothaman, B; Ramaskandhan, J; Webb, M; Weusten, A | 1 |
Beattie, WS; Carroll, J; Grewal, D; Harsha, P; Karkouti, K; Ragoonanan, T; Starzyk, Ł; Syed, S; Travis, G; Wąsowicz, M; Wijeysundera, DN | 1 |
Agostoni, P; Baan, J; Bennaghmouch, N; Collet, JP; den Heijer, P; Deneer, VH; Hassell, M; Huber, K; Kelder, JC; Kievit, PC; Latib, A; Maisano, F; Nijenhuis, VJ; Onorati, F; Stella, PR; Ten Berg, JM; van 't Hof, A; van den Heuvel, AF; van der Harst, P; van der Kley, F; van Kuijk, JP; Veenstra, L | 1 |
Hosogoe, N; Ishikawa, S; Isshiki, T; Kozuma, K; Watanabe, Y | 1 |
Berger, JS; Smilowitz, NR | 1 |
Burkert, B; Hummel, T; Meves, SH; Mügge, A; Mühlberger, D; Mumme, A; Neubauer, H; Rüdiger, K | 1 |
Alhefdhi, AY; Chen, H; Oltmann, SC; Rajaei, MH; Schneider, DF; Sippel, RS | 1 |
Aquino, M; Baber, U; Baker, B; Chandrasekhar, J; DeFranco, A; Effron, M; Faggioni, M; Henry, T; Kapadia, S; Keller, S; Kini, A; Mehran, R; Muhlestein, B; Pocock, S; Rao, S; Sartori, S; Strauss, C; Toma, C; Weintraub, W; Weiss, S | 1 |
Liu, L; Zhang, F | 1 |
Dadjou, Y; Kojuri, J; Safavi, S | 1 |
Cattaneo, M; Cipriani, M; Femia, EA; Frigerio, M; Morici, N; Oliva, F; Perna, E | 1 |
Delgado Almandoz, JE; Fease, JL; Kayan, Y; Milner, AM; Mulder, M; Scholz, JM | 1 |
Gearman, DJ; Ingimarsson, JP; Krambeck, AE; Scales, J; Sharma, V; Westerman, ME | 1 |
Broderick, TM; Dalia, AA; Essandoh, MK; Flores, AS; George, BS; Kirtane, AJ; Otey, AJ; Rao, SV | 1 |
Alexander, JH; Kalil, RA; Lopes, RD; Mehta, RH; Newby, LK; Prates, PR; Smith, PK; Stevens, SR; Thomas, L; Williams, JB | 1 |
Abizaid, A; Bhatt, DL; Chieffo, A; Colombo, A; Costa, RA; Feres, F; Genereux, P; Gilard, M; Giustino, G; Hong, MK; Jang, Y; Kim, BK; Kim, HS; Leon, MB; Morice, MC; Palmerini, T; Park, KW; Redfors, B; Sardella, G; Sawaya, F; Stone, GW; Valgimigli, M | 1 |
Bensalah, K; Khene, Z; Mathieu, R; Peyronnet, B; Pradere, B; Roupret, M; Ruggiero, M; Seisen, T; Vaessen, C; Verhoest, G | 1 |
Beuil, S; Chau, Y; Gaudart, J; Lonjon, M; Sachet, M; Sedat, J | 1 |
Fichter, AM; Mitchell, DA; Mücke, T; Ritschl, LM; Robitzky, LK; Wagenpfeil, S; Wolff, KD | 1 |
Mukherjee, D; Naidu, SS; Nairooz, R; Pothineni, NV; Raina, S; Rochlani, Y; Sardar, P; Shavelle, DM; Valgimigli, M | 1 |
Ariotti, S; Franzone, A; Gargiulo, G; Heg, D; Magnani, G; Marino, M; Piccolo, R; Santucci, A; Tebaldi, M; Valgimigli, M; Windecker, S | 1 |
Farkouh, ME; Fuster, V; Goodman, SG; Hamza, TH; Siami, FS; van Diepen, S; Verma, S | 1 |
Ata, N; Birdane, A; Çolak, E; Değirmenci, İ; Güneş, HV; Özbayer, C; Özdemir, M; Saydam, F; Ulus, T | 1 |
Artemiou, P; Bena, M; Gasparovic, I; Hudec, V; Hulman, M | 1 |
Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Wada, T; Yamada, S; Yokoyama, S | 1 |
Cho, SY; Choi, D; Choi, JR; Chung, N; Ha, JW; Jang, Y; Kim, JS; Ko, YG; Park, S; Shim, CY; Shim, WH; Yoon, SJ | 1 |
Johansen, A; Turk, A; White, J | 1 |
Barthwal, R; Herman, BA | 1 |
Patel, RA; White, CJ | 1 |
Bresnahan, JF; Gumina, RJ; Holmes, DR; Lennon, RJ; Prasad, A; Rihal, CS; Sandhu, GS; Singh, M; Yang, EH | 1 |
Garcia-Rinaldi, RF; Macdonald, RJ; McKellar, SH; Schaff, HV; Sundt, TM; Thompson, JL | 1 |
Alfonso, F; Angel, J; Bañuelos, C; Bethencourt, A; Cequier, A; Escaned, J; Hernández, R; Iñiguez, A; Jiménez-Quevedo, P; López-Mínguez, JR; Macaya, C; Martí, V; Morís, C; Pérez-Vizcayno, MJ; Sabaté, M; Suárez, A | 1 |
Crousier, M; Demaret, C; Ffrench, P; Hanss, M; Piriou, V | 1 |
Alonso Orcajo, N; Alonso Rodríguez, D; Carbonell de Blas, R; Cuellas Ramón, C; de Miguel Castro, A; Diego Nieto, A; Fernández Vázquez, F; Pascual Vicente, C; Pérez de Prado, A; Samaniego Lampón, B | 1 |
Chan, V; Kulik, A; Ruel, M | 1 |
Argüello Viudez, L | 1 |
Airoldi, F; Aranzulla, TC; Carlino, M; Castelli, A; Chieffo, A; Colombo, A; Cosgrave, J; Godino, C; Latib, A; Magni, V; Michev, I; Montorfano, M; Rogacka, R; Romagnoli, E; Sangiorgi, GM | 1 |
Fuller, M; Misra, S; Muldowney, JA; Pecot, CV | 1 |
Fischer, A; Hopt, UT; Marjanovic, G; Olschewski, M; Richter, S; Ruthmann, O; Schrag, HJ; Seitz, A | 1 |
Gao, C; Li, D; Li, L; Ren, C | 1 |
Hopkins, LN; Ionita, CC; Levy, EI; Natarajan, SK; Siddiqui, AH; Snyder, KV | 1 |
Ak, K; Arsan, S; Eksioglu-Demiralp, E; Iqbal, O; Isbir, S; Tetik, S; Yardimci, T | 1 |
Motovska, Z; Widimsky, P | 1 |
Bae, JP; Dobesh, PP; Khoynezhad, A; McCollam, PL | 1 |
Akin, I; Chatterjee, A; Chatterjee, T; Ince, H; Nienaber, CA; Rehders, TC; Schüpfer, C | 1 |
Adams, S; Daskalakis, C; Hohmann, S; Kim, DH; Lee, AN; Medvedev, S; Sheth, MP; Silvestry, SC; Whellan, DJ | 1 |
Janion, M; Polewczyk, A; Sielski, J; Wałek, P | 1 |
Cohen, GN; Fawzy, HF; Fremes, SE; Goldman, BE; Laflamme, C; Nesher, N; Sever, JY; Singh, SK | 1 |
Abla, AA; Killory, BD; Nakaji, P; Spetzler, RF; Starke, RM; Wait, SD | 1 |
Hadad, E; Kramer, E; Shalom, A; Westreich, M | 1 |
Bal, ET; Bouman, HJ; Breet, NJ; Deneer, VH; Hackeng, CM; Harmsze, AM; Kelder, JC; Rensing, BJ; Ruven, HJ; Suttorp, MJ; ten Berg, JM; van der Heyden, JA; van Werkum, JW | 1 |
Akbary, H; Fuleihan, SF; Osta, WA | 1 |
Doraiswamy, VA | 1 |
García-Bracamonte, B; Vanaclocha, F | 1 |
Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Robijns, K; Ruven, HJ; Ten Berg, JM; van Werkum, JW | 1 |
Carroll, NM; DeFor, TA; Go, AS; Ho, PM; Jackevicius, C; Maddox, TM; Magid, DJ; Margolis, KL; Powers, JD; Rumsfeld, JS; Tsai, TT | 1 |
Anselmino, M; Moretti, C; Ravera, L; Sheiban, I | 1 |
Dennis, MJ; London, NJ; McCarthy, MJ; Nasim, A; Naylor, AR; Sayers, RD; Sharpe, RY | 1 |
Farrell, ED; Hume, EL; Marburger, R; Marcantonio, AJ; Nydick, JA; Ostrum, RF | 1 |
Hamm, CW; Möllmann, H; Nef, HM | 1 |
Price, MJ | 1 |
Berger, PB; Kalyanasundaram, A | 1 |
Fortuna, A; Hodgson, RE; Miller, SM | 1 |
Harrison, GR | 1 |
Barthélémy, O; Bellemain-Appaix, A; Beygui, F; Brieger, D; Cayla, G; Collet, JP; Montalescot, G; Pena, A; Silvain, J | 1 |
Abdel-Karim, AR; Banerjee, S; Brilakis, ES; Gandhi, NK | 1 |
Bax, JJ; Boersma, EE; Chonchol, M; Flu, WJ; Hoeks, SE; Poldermans, D; Schouten, O; van Kuijk, JP; Verhagen, HJ; Voute, MT | 1 |
Han, MH; Jung, C; Kang, HS; Kim, JE; Kwon, BJ; Kwon, OK; Oh, CW | 1 |
Albert, MA; Compton, CJ; Feist, RM; Frederick, PA; Gupta, SR; Heersink, MJ; Hill, ML; Mason, JO; Neimkin, MG; Thomley, ML; Vail, RS; White, MF | 1 |
Amorós, S; Fernández-Sender, L; Marsal, J; Martínez-Cerezo, FJ; Pascual, D; Tena, FJ | 1 |
Bae, JH; Bae, JW; Chae, IH; Cho, MC; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Koo, BK; Kwon, TG; Lee, HY; Lee, SP; Park, KW; Rha, SW; Suh, JW; Youn, TJ | 1 |
Bonatti, J; Zimrin, D | 1 |
Suissa, S; Vaduganathan, M | 1 |
Savage, EB | 1 |
Abi Rached, J; Ayoub, I; El-Sayegh, S; Geara, AS; Ghimire, P; Siddique, MN | 1 |
Fiorella, D; Klisch, J; Turk, A; Turner, R; Woo, HH | 1 |
Hayashi, K; Hiu, T; Kawakubo, J; Kitagawa, N; Morikawa, M; Morofuji, Y; Nagata, I; So, G; Suyama, K | 1 |
Brewer, JD; Cook-Norris, RH; Michaels, JD; Otley, CC; Phillips, PK; Roenigk, RK; Weaver, AL | 1 |
Dart, AM; Fernando, H; Peter, K; Shaw, JA | 1 |
Satler, LF | 1 |
Athanasiou, T; Malik, IS; Nijjer, SS; Watson, G | 1 |
Barequet, IS; Budnik, I; Moisseiev, J; Priel, A; Sachs, D; Salomon, O; Shenkman, B; Wasserzug, Y | 1 |
Bordeaux, JS; Fu, P; Goldberg, D; Maloney, ME; Martires, KJ; Pattee, SF | 1 |
Dimech, J; Duggie, AJ | 1 |
Brown, JS; Mahmoud, TH | 1 |
Clough, TM; Jones, M; Nwachuku, IC | 1 |
Ana, G; António, F; Cardona, L; Cruz, FR; Leal, A; Lídia, S; Luísa, B | 1 |
Mascarenhas, L | 1 |
Brar, SS; Breet, NJ; Cuisset, T; Dangas, G; DiSciascio, G; Kim, HS; Marcucci, R; Patti, G; Price, MJ; ten Berg, J; Valgimigli, M | 1 |
Hochholzer, W; Wiviott, SD | 1 |
Buntic, R; Parrett, BM; Singer, M; Woo, A | 1 |
Bosticco, B; Brizzio, ME; Collins, M; Grau, JB; Mak, AW; Shaw, RE; Zapolanski, A | 1 |
Agnani, S; Akkus, NI; Rajpal, S | 1 |
Correa, ZM; Foster, RE; Malik, AI; Miller, DM; Petersen, MR; Riemann, CD | 1 |
Bernlochner, I; Braun, S; Byrne, RA; Gebhard, D; Jaitner, J; Kastrati, A; Koch, W; Mehilli, J; Morath, T; Schömig, A; Schulz, S; Sibbing, D | 1 |
Adams, H; Albers, GW; Felberg, R; Furlan, AJ; Herrmann, H; Kar, S; Landzberg, M; Massaro, J; Mauri, L; Raizner, A; Reisman, M; Wechsler, L | 1 |
Airaksinen, KE; Biancari, F; Karjalainen, P; Kiviniemi, T; Niemelä, M; Pietilä, M; Puurunen, M; Vikman, S; Ylitalo, A | 1 |
Armero, S; Barragan, P; Berbis, J; Bessereau, J; Bonello, C; Bonello, L; Camillieri, E; Camoin-Jau, L; Dignat-George, F; Jacquin, L; Laine, M; Paganelli, F | 1 |
Babic, D; Homan, R; Islak, C; Kizilkilic, O; Kocer, N; Metaxas, GE | 1 |
Bessereau, J; Bonello, L; Camoin-Jau, L; Paganelli, F; Uhry, S | 1 |
Antonijevic, N; Asanin, M; Kocev, N; Krljanac, G; Lasica, R; Marinkovic, J; Mrdovic, I; Perunicic, J; Savic, L; Vasiljevic, Z | 1 |
Freynhofer, MK; Höchtl, T; Huber, K; Mahla, E; Prüller, F | 1 |
Barbato, E; D'Ambrosio, A; Di Sciascio, G; Mangiacapra, F; Orlic, D; Ostojic, M; Patti, G; Peace, AJ; Wijns, W | 1 |
Angelini, GD; Aresu, G; Caputo, M; de Siena, PM; Duggan, SM; Glauber, M; Miceli, A; Romeo, F | 1 |
Gregory Thompson, B; Rohatgi, P; Than, KD; Wilson, TJ | 1 |
Ballarín, J; Canal, C; de la Torre, P; Del Pozo, M; Díaz, JM; Facundo, C; Guirado, L; Martí, J | 1 |
Fujikawa, T; Maekawa, H; Shiraishi, K; Tanaka, A | 1 |
Sadanandan, S; Singh, IM | 1 |
Bergert, H; Bötticher, G; Gäbel, G; Saeger, HD; Weiss, N | 1 |
Feng, YP; Guo, MM; Hu, L; Li, HL; Liang, GZ; Long, YY; Luo, XY; Ma, BB; Niu, LY; Qi, HS; Zhang, CM; Zhang, FX; Zhang, H | 1 |
Alaraj, A; Aletich, VA; Amin-Hanjani, S; Carlson, AP; Charbel, FT | 1 |
Kompatscher, P; Riml, S; Wallner, H | 1 |
Do, HM; Mitchell, LA; Santarelli, JG; Singh, IP | 1 |
Turpie, AG | 1 |
Hiller, E | 1 |
Banning, AP; Clarke, NR; Timperley, J | 1 |
Alam, M; Goldberg, LH | 1 |
Buettner, HJ; Hunziker, P; Marsch, S; Mueller, C; Neumann, FJ; Perruchoud, A; Roskamm, H | 1 |
Rott, D | 1 |
Barry, WH; Coletti, AT; Jessup, DB; Muhlestein, JB; Shean, FC; Whisenant, BK | 1 |
Baralis, G; Dellavalle, A; La Scala, E; Steffenino, G; Uslenghi, E | 1 |
Ching, JY; Chung, SC; Hui, AJ; Hung, LC; Sung, JJ; Wong, RM | 1 |
Colombo, A; Desmedt, B; Di Mario, C; Holmes, DR; Leon, MB; Louvard, Y; Ludwig, J; Morice, MC; Moses, JW; Spanos, V | 1 |
Bell, PR; Goodall, AH; Hayes, PD; Jones, CI; London, NJ; Naylor, AR; Payne, DA; Thompson, MM | 1 |
Kastrati, A; Schömig, A; Schömig, E | 1 |
Ferguson, JJ | 1 |
Kiemeneij, F; Laarman, GJ; Riezebos, RK; Slagboom, T; van der Heijden, DJ; van der Wieken, LR; Westendorp, IC | 1 |
Stadius, ML | 1 |
Casselman, FP; Dom, H; Foubert, L; Meco, M; Van Praet, F; Vanermen, H | 1 |
Dambrink, JH; de Boer, MJ; Ernst, NM; Gosselink, AT; Hoorntje, JC; Miedema, K; Ottervanger, JP; Slingerland, RJ; Suryapranata, H; van 't Hof, AW; Zijlstra, F | 1 |
Bagaev, E; Beilner, J; Haverich, A; Kirschner, S; Klima, U; MacVaugh, H; Maringka, M | 1 |
Choudhury, A; Fisher, E; Kim, MC; Kini, AS; Lee, J; Sharma, SK; Steinheimer, AM | 1 |
Chu, MW; Novick, RJ; Quantz, MA; Stitt, LW; Wilson, SR | 1 |
Bafi, AS; Boyce, SW; Corso, PJ; Dullum, MK; Haile, E; Hill, PC; Kapetanakis, EI; Medlam, DA; Petro, KR | 1 |
Bavry, AA; Bhatt, DL; Helton, TJ; Kumbhani, DJ | 1 |
Akan, M; Aköz, T; Cakir, B; Misirlioğlu, A; Taylan, G; Yildirim, S | 1 |
Bliden, KP; Gurbel, PA; Hayes, KM; Herzog, WR; Tantry, US; Yoho, JA | 1 |
Bazemore, E; Jobe, RL; Mann, T; Schneider, JE; Wood, F | 1 |
Gluckman, TJ; Rade, JJ; Schulman, SP | 1 |
Al-Bustami, O; Burks, J; Dehghani, M; Emrani, F; Mehdipour, M; Sharifi, M | 1 |
Cay, S; Korkmaz, S; Yilmaz, MB | 1 |
Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT | 1 |
Eriksson, P | 1 |
Doerfler, A; Forsting, M; Gizewski, ER; Goericke, S; Moemken, S; Sandalcioglu, E; Stolke, D; Wanke, I | 1 |
Fletcher, JP; Hitos, K | 1 |
García-Rinaldi, R | 1 |
Berger, PB; Brennan, DM; Steinhubl, SR; Topol, EJ | 1 |
Gulba, DC; Klutmann, M; Tillmanns, C | 1 |
Batisse, A; Batisse, JP; Beygui, F; Choussat, R; Collet, JP; Helft, G; Le Feuvre, C; Metzger, JP; Montalescot, G | 1 |
Hetzer, R; Potapov, EV | 1 |
Brittenden, J; Collins, P; Ford, I; Greaves, M; Macaulay, E | 1 |
Dehmer, GJ; McAllister, RK; Meyer, TA | 1 |
Dib, JC; Digne, F; Dubois, C; Estagnasié, P; Gérardin, B; Grinda, JM; Pillière, R; Terdjman, M | 1 |
Goodall, AH; Hayes, PD; Jones, CI; Naylor, AR; Payne, DA | 1 |
Dunning, J; Hooper, T; Hoschtitzky, A; Ziegelin, M | 1 |
Spiess, BD | 1 |
van der Linden, J | 1 |
Augoustides, JG | 1 |
Abbate, A; Agostoni, P; Alessi, MC; Angiolillo, DJ; Biondi-Zoccai, GG; Collet, JP; Cuisset, T; Di Sciascio, G; Laudito, A; Lotrionte, M; Meliga, E; Montalescot, G; Moretti, C; Sangiorgi, G; Sheiban, I; Testa, L; Trevi, GP; Valgimigli, M; Waksman, R | 1 |
Demers Lavelle, EA; Lavelle, WF; Uhl, R | 1 |
Edovina, LN; Luk'ianov, IuV; Parusova, EV; Sokurenko, GIu | 1 |
Collins, M; Colombo, A; Iyer, S; Kreps, E; Maida, R; Moses, JW; Moussa, I; Oetgen, M; Roubin, G; Wang, X | 1 |
Jafary, FH; Kimmelstiel, CD | 1 |
Büttner, HJ; Müller, C; Petersen, J; Roskamm, H | 1 |
Miller, JL | 1 |
Berger, PB | 1 |
Blows, LJ; Calver, AL; Dawkins, KD; Gray, HH; Harmer, S; Morgan, JH; Simpson, IA | 1 |
Bhatt, DL; Chew, DP; Hacke, W; Hirsch, AT; Ringleb, PA; Topol, EJ | 1 |
Griffo, R | 1 |
Dangas, G | 1 |
Yende, S | 1 |
Bergsland, J; D'Ancona, G; Donias, HW; Karamanoukian, HL; Karamanoukian, RL | 1 |
Botey, A; Cases, A; Pou, M; Vera, M | 1 |
37 review(s) available for clopidogrel and Complication, Postoperative
Article | Year |
---|---|
A Systematic Review and Meta-Analysis on the Impact of High On-Treatment Platelet Reactivity on Clinical Outcomes for Patients Taking ADP Receptor Inhibitors Following Lower Limb Arterial Endovascular Intervention.
Topics: Cause of Death; Clopidogrel; Endovascular Procedures; Humans; Lower Extremity; Peripheral Arterial Disease; Platelet Activation; Platelet Function Tests; Postoperative Complications; Postoperative Hemorrhage; Purinergic P2 Receptor Antagonists; Treatment Outcome | 2022 |
Syncope After Percutaneous Coronary Intervention.
Topics: Clopidogrel; Coronary Artery Bypass; Coronary Stenosis; Drug Substitution; Drug-Eluting Stents; Electrocardiography; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Care; Postoperative Complications; Syncope; Ticagrelor; Time Factors; Treatment Outcome | 2019 |
Very short dual antiplatelet therapy after PCI and new DES: a meta-analysis of 5 randomized trials.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Ticagrelor; Time Factors; Treatment Outcome | 2021 |
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Hemorrhage; Humans; Percutaneous Coronary Intervention; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Ticagrelor; Withholding Treatment | 2020 |
Antithrombotic therapy with or without clopidogrel after transcatheter aortic valve replacement. A meta-analysis of randomized controlled trials.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Transcatheter Aortic Valve Replacement | 2022 |
Comparison of single versus dual antiplatelet therapy after TAVR: A systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Risk Factors; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2018 |
Triple therapy: worth the risk?
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitors; Hemorrhage; Humans; Mortality; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Rivaroxaban; Stents; Stroke; Thrombophilia; Ticlopidine | 2018 |
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis.
Topics: Acute Coronary Syndrome; Clinical Protocols; Clinical Trials as Topic; Clopidogrel; Humans; Percutaneous Coronary Intervention; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Risk; Survival Analysis; Ticagrelor; Time Factors | 2019 |
Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
Topics: Aortic Valve Stenosis; Aspirin; Cardiac Catheterization; Clopidogrel; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Ticlopidine; Time Factors | 2013 |
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
Topics: Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Models, Statistical; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 2013 |
Diagnosis and management of carotid atherosclerosis.
Topics: Carotid Artery Diseases; Carotid Artery, Common; Clopidogrel; Endarterectomy, Carotid; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Patient Safety; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Prognosis; Risk Assessment; Severity of Illness Index; Stroke; Survival Analysis; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Duplex; United Kingdom | 2013 |
Perioperative management of anticoagulation in elective surgery.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Diseases; Clopidogrel; Dabigatran; Elective Surgical Procedures; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Thromboembolism; Ticlopidine; Withholding Treatment | 2013 |
Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Postoperative Complications; Ticlopidine | 2013 |
Aspirin, clopidogrel, and the surgeon.
Topics: Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Practice Guidelines as Topic; Preoperative Care; Risk Assessment; Thienopyridines; Ticlopidine; Time Factors; Withholding Treatment | 2014 |
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Survival Analysis; Ticlopidine; Transcatheter Aortic Valve Replacement; Treatment Outcome; Ultrasonography | 2015 |
Perioperative Management to Reduce Cardiovascular Events.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Contraindications; Coronary Disease; Disease Susceptibility; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Preanesthetic Medication; Risk Factors; Risk Reduction Behavior; Stress, Physiological; Surgical Procedures, Operative; Thrombophilia; Ticlopidine | 2016 |
Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy.
Topics: Acute Coronary Syndrome; Clopidogrel; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Ticlopidine | 2017 |
Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Administration Schedule; Drug Therapy, Combination; Humans; Meta-Analysis as Topic; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Randomized Controlled Trials as Topic; Risk Assessment; Ticlopidine | 2009 |
Clopidogrel before elective percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Elective Surgical Procedures; Humans; Postoperative Complications; Preoperative Care; Randomized Controlled Trials as Topic; Ticlopidine | 2010 |
[Perioperative antiplatelet therapy of patients with coronary stents].
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Disease; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Stents; Thrombosis; Ticlopidine; Time Factors | 2009 |
New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Postoperative Complications; Purinergic P2 Receptor Antagonists; Quinazolinones; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Sulfonamides; Ticlopidine | 2010 |
Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy.
Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Interactions; Enzyme Activation; Genetic Testing; Humans; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Postoperative Complications; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome | 2011 |
Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies.
Topics: Acute Coronary Syndrome; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critical Care; Female; Hemorrhage; Humans; Length of Stay; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Reoperation; Research Design; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2011 |
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine | 2011 |
Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Resistance; Evidence-Based Medicine; Genotype; Humans; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine | 2012 |
[Platelet function: new drugs, new assays : possible impacts on operative medicine?].
Topics: Adenosine; Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Postoperative Complications; Postoperative Hemorrhage; Practice Guidelines as Topic; Prasugrel Hydrochloride; Predictive Value of Tests; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine | 2012 |
Clopidogrel: the data, the experience, and the controversies.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Ticlopidine | 2012 |
[Antithrombotic therapy after peripheral vascular treatment: what is evidence-based?].
Topics: Aortic Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endarterectomy; Evidence-Based Medicine; Femoral Artery; Fibrinolytic Agents; Follow-Up Studies; Humans; Iliac Artery; International Normalized Ratio; Peripheral Arterial Disease; Polyethylene Terephthalates; Polytetrafluoroethylene; Popliteal Artery; Postoperative Complications; Prosthesis Design; Ticlopidine; Veins; Vitamin K | 2012 |
State of the art--a journey through the world of antithrombotic therapy.
Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Heart Failure; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Orthopedic Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Recurrence; Respiratory Insufficiency; Thromboembolism; Thrombolytic Therapy; Thrombophlebitis; Thrombosis; Ticlopidine | 2002 |
[Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Thrombosis; Ticlopidine | 2003 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2005 |
[Very late intrastent thrombosis--at 27 months!].
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Fatal Outcome; Flurbiprofen; Follow-Up Studies; Hernia, Inguinal; Humans; Laparoscopy; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine | 2007 |
Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery?
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Postoperative Complications; Proton Pump Inhibitors; Ticlopidine | 2007 |
Con: continuation of aspirin/clopidogrel for cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Drug Therapy, Combination; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prognosis; Thrombosis; Ticlopidine | 2007 |
Pro: continuation of aspirin/clopidogrel for cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Heart Diseases; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prognosis; Thrombosis; Ticlopidine | 2007 |
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Ticlopidine | 2007 |
Antiplatelet therapy in interventional cardiology: I. Newer oral antiplatelet agents.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Drug Administration Schedule; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Stents; Thrombosis; Ticlopidine | 2000 |
58 trial(s) available for clopidogrel and Complication, Postoperative
Article | Year |
---|---|
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.
Topics: Aged; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; ST Elevation Myocardial Infarction; Survival Analysis; Thrombosis; Ticagrelor; Treatment Outcome | 2020 |
Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial.
Topics: Angioplasty; Aspirin; Clopidogrel; Critical Illness; Factor Xa Inhibitors; Humans; Ischemia; Leg; Multicenter Studies as Topic; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Popliteal Artery; Postoperative Complications; Proof of Concept Study; Prospective Studies; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Thrombosis | 2020 |
Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Dual Anti-Platelet Therapy; Duration of Therapy; Female; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Migraine Disorders; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications | 2021 |
Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Propensity Score; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial.
Topics: Adenosine Monophosphate; Administration, Oral; Aged; Cause of Death; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Global Health; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Survival Rate; Ticlopidine; Time Factors | 2017 |
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).
Topics: Adenosine Monophosphate; Aged; Anticoagulants; Clopidogrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Intraoperative Period; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Treatment Outcome | 2017 |
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study.
Topics: Aged; Aryldialkylphosphatase; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Postoperative Complications; Receptors, Purinergic P2Y12; Thrombosis; Ticlopidine | 2018 |
Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting.
Topics: Aged; Aspirin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Costs and Cost Analysis; Drug Therapy, Combination; Female; Hospitals, Veterans; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Treatment Outcome | 2018 |
Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Incidence; Male; Myocardial Infarction; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Survival Rate; Time Factors; Treatment Outcome; United States | 2018 |
The Incidence of Myocardial Injury after Loading Doses of Clopidogrel versus Prasugrel in the Candidates for Percutaneous Coronary Intervention: A Randomized Controlled Trial.
Topics: Adult; Angina, Stable; C-Reactive Protein; Clopidogrel; Creatine Kinase, MB Form; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Troponin I | 2018 |
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Clopidogrel; Female; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Thromboembolism; Warfarin | 2018 |
Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Revascularization; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Treatment Outcome | 2018 |
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPIO
Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States | 2018 |
Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).
Topics: Aged, 80 and over; Aortic Valve Stenosis; Clopidogrel; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; Humans; Incidence; Male; North America; Postoperative Complications; Preoperative Care; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Assessment; Risk Factors; Thromboembolism; Time Factors; Transcatheter Aortic Valve Replacement | 2019 |
Anterior chamber bleeding after laser peripheral iridotomy.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anticoagulants; Aspirin; Clopidogrel; Eye Color; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Hyphema; Incidence; Intraocular Pressure; Iridectomy; Iris; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Risk Factors; Ticlopidine; Tonometry, Ocular; Warfarin | 2013 |
Combination of high on-treatment platelet aggregation and low deaggregation better predicts long-term cardiovascular events in PCI patients under dual antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Artery Disease; Disease-Free Survival; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Predictive Value of Tests; Survival Rate; Ticlopidine | 2014 |
Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Restenosis; Female; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Stroke; Ticlopidine | 2014 |
Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Croatia; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Male; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Retrospective Studies; Survival Rate; Ticlopidine; Treatment Outcome | 2014 |
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.
Topics: Aged; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Predictive Value of Tests; Risk Assessment; Saphenous Vein; Ticlopidine; Vascular Patency | 2014 |
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP2C19; Double-Blind Method; Elective Surgical Procedures; Female; Follow-Up Studies; Gene Frequency; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Ticlopidine | 2014 |
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Early Termination of Clinical Trials; Europe; Everolimus; Female; Hemorrhage; Humans; Immunosuppressive Agents; Male; Middle Aged; Middle East; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome | 2015 |
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates.
Topics: Aged; Aged, 80 and over; Aspirin; Biocompatible Materials; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hemorrhage; Humans; Immunosuppressive Agents; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Treatment Outcome | 2015 |
Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.
Topics: Aged; Antithrombins; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Hirudins; Humans; Male; Middle Aged; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Postoperative Complications; Prospective Studies; Recombinant Proteins; Secondary Prevention; ST Elevation Myocardial Infarction; Survival Rate; Thrombolytic Therapy; Ticlopidine; Treatment Outcome | 2017 |
Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Survival Analysis; Thrombosis; Ticlopidine; Ultrasonography, Interventional | 2015 |
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
Topics: Aged; Blood Vessel Prosthesis Implantation; Clopidogrel; Drug Interactions; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Platelet Activation; Postoperative Complications; Prospective Studies; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome; United States | 2015 |
Pre-PCI medication using clopidogrel and ticagrelor in the treatment of patients with acute myocardial infarction.
Topics: Adenosine; Aged; Clopidogrel; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Ticagrelor; Ticlopidine; Treatment Outcome | 2015 |
Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study.
Topics: Aged; Aspirin; Cardiomyopathy, Dilated; Clopidogrel; Cohort Studies; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Surgical Procedures, Operative; Ticlopidine; Treatment Outcome; Troponin I | 2016 |
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
Topics: Administration, Oral; Aortic Valve Stenosis; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Incidence; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prospective Studies; Survival Rate; Thromboembolism; Ticlopidine; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2016 |
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Stenosis; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Long-Term Care; Male; Middle Aged; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Postoperative Complications; Risk Factors; Ticlopidine | 2016 |
Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine | 2017 |
Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Stroke; Tetrazoles; Ticlopidine | 2017 |
The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation.
Topics: Aged; Cardiovascular Surgical Procedures; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine | 2009 |
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Sirolimus; Ticlopidine | 2008 |
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Female; Graft Occlusion, Vascular; Graft Rejection; Graft Survival; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Probability; Prognosis; Survival Rate; Ticlopidine; Treatment Outcome; Vascular Patency | 2009 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Prospective Studies; Pyrroles; Ticlopidine | 2010 |
Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Predictive Value of Tests; Prospective Studies; Stents; Stroke; Thrombosis; Ticlopidine; Treatment Outcome | 2010 |
The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applyin
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Echocardiography, Stress; Humans; Myocardial Infarction; Myocardial Ischemia; Netherlands; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Research Design; Ticlopidine; Troponin T; Vascular Surgical Procedures | 2010 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prostheses and Implants; Secondary Prevention; Stroke; Ticlopidine; Warfarin; Young Adult | 2012 |
Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.
Topics: Aged; Aspirin; Clopidogrel; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYo
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Dose-Response Relationship, Drug; Humans; Internationality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Ticlopidine; Treatment Outcome | 2012 |
Angioplasty and stent treatment of transplant renal artery stenosis.
Topics: Adult; Aged; Angioplasty; Anticoagulants; Aspirin; Clopidogrel; Female; Follow-Up Studies; Humans; Hypertension, Renovascular; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Renal Artery Obstruction; Risk Factors; Stents; Ticlopidine; Treatment Outcome; Ultrasonography | 2012 |
[A prospective randomized control clinical trial about clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after femoral-popliteal artery angioplasty].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Clopidogrel; Female; Femoral Artery; Humans; Male; Middle Aged; Popliteal Artery; Postoperative Complications; Prospective Studies; Ticlopidine; Warfarin | 2012 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.
Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Survival Rate; Ticlopidine; Time Factors | 2003 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Death, Sudden; Diabetes Mellitus; Disease-Free Survival; Drug Implants; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Safety; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome | 2004 |
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Disease Progression; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Humans; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Premedication; Risk; Ticlopidine; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Wound Healing | 2004 |
Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Angiography; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Female; Follow-Up Studies; Humans; Isoenzymes; Male; Middle Aged; Myocardial Infarction; Netherlands; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome; Troponin I | 2004 |
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Survival Analysis; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
Magnetic Vascular Port in minimally invasive direct coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Comorbidity; Coronary Angiography; Drug Therapy, Combination; Equipment Design; Female; Follow-Up Studies; Humans; Internal Mammary-Coronary Artery Anastomosis; Magnetics; Male; Middle Aged; Minimally Invasive Surgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Surgical Instruments; Thrombosis; Ticlopidine; Treatment Outcome; Vascular Patency | 2004 |
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2005 |
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.
Topics: Adenosine Diphosphate; Aged; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome | 2005 |
Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Ticlopidine; Time Factors | 2006 |
Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Clopidogrel; Contrast Media; Coronary Angiography; Drug Delivery Systems; Enoxaparin; Female; Humans; Incidence; Ioxaglic Acid; Male; Middle Aged; Osmolar Concentration; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Risk Factors; Stents; Thrombosis; Ticlopidine; Triiodobenzoic Acids | 2006 |
Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Body Weight; Clopidogrel; Endarterectomy, Carotid; Humans; Placebos; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Statistics as Topic; Thrombosis; Ticlopidine | 2007 |
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Diarrhea; Drug Eruptions; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Neutropenia; Platelet Aggregation Inhibitors; Postoperative Complications; Safety; Stents; Ticlopidine; Treatment Outcome | 1999 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome | 2000 |
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery.
Topics: Aspirin; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Female; Hospitalization; Humans; Ischemia; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine | 2001 |
194 other study(ies) available for clopidogrel and Complication, Postoperative
Article | Year |
---|---|
In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Japan; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Registries; Retrospective Studies; Warfarin | 2021 |
Is it Safe to Continue Clopidogrel in Elective Hip and Knee Arthroplasty?
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Clopidogrel; Elective Surgical Procedures; Hemorrhage; Humans; Length of Stay; Postoperative Complications; Retrospective Studies | 2022 |
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial.
Topics: Aged; Aspirin; Chromium Alloys; Clopidogrel; Coronary Restenosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Humans; Incidence; Japan; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Proportional Hazards Models; Randomized Controlled Trials as Topic; Single-Blind Method; Stroke | 2019 |
Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples.
Topics: Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; DNA; Dual Anti-Platelet Therapy; Genotyping Techniques; Humans; Mouth Mucosa; Percutaneous Coronary Intervention; Pharmacogenomic Testing; Pharmacogenomic Variants; Pharmacology, Clinical; Postoperative Complications; Reagent Kits, Diagnostic; Reference Standards; Reproducibility of Results; Stents; Thrombosis; Time Factors | 2020 |
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Female; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Recurrence; Registries; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors | 2020 |
Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopidogrel; Drainage; Female; Heparin, Low-Molecular-Weight; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; Phenprocoumon; Postoperative Complications; Prothrombin Time; Retinal Detachment; Retinal Hemorrhage; Retrospective Studies; Risk Factors; Scleral Buckling; Subretinal Fluid; Vitrectomy | 2020 |
Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping.
Topics: Adult; Aged; Blood Platelets; Carotid Arteries; Clopidogrel; Dose-Response Relationship, Drug; Endovascular Procedures; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Thrombelastography; Thromboembolism; Thrombosis | 2020 |
Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage?
Topics: Aspirin; Cataract; Clopidogrel; Humans; Lens Implantation, Intraocular; Phacoemulsification; Postoperative Complications; Risk Factors; Visual Acuity | 2020 |
Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Retrospective Studies; Thromboembolism; Ticagrelor; Treatment Outcome; United States | 2020 |
Antiplatelet Therapy in Patients Without a Coronary Stent and Mortality After Noncardiac Surgery.
Topics: Adult; Aged; Aspirin; Clopidogrel; Elective Surgical Procedures; Female; Hospital Mortality; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |
Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant).
Topics: Acute Coronary Syndrome; Aged; Clinical Decision Rules; Clopidogrel; Cohort Studies; Female; Gastrointestinal Hemorrhage; Heart Failure; Humans; Male; Middle Aged; Partial Thromboplastin Time; Peptic Ulcer; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Renal Insufficiency; Research Design; Risk Assessment | 2020 |
Thrombosis of a Percutaneous Transcatheter Mitral Valve Implant and Its Treatment.
Topics: Anticoagulants; Bioprosthesis; Cardiac Catheterization; Clopidogrel; Coronary Artery Disease; Echocardiography; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pyrazoles; Pyridones; Thrombosis; Treatment Outcome; Withholding Treatment | 2020 |
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry.
Topics: Clopidogrel; Continuity of Patient Care; COVID-19; Feasibility Studies; Follow-Up Studies; Genotype; Geographic Information Systems; Health Surveys; Humans; Internet-Based Intervention; Ischemia; Mobile Applications; Multicenter Studies as Topic; Patient Compliance; Patient Generated Health Data; Patient Participation; Percutaneous Coronary Intervention; Postoperative Complications; Pragmatic Clinical Trials as Topic; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Registries; Research Design; SARS-CoV-2; Telephone | 2021 |
Adjunctive treatment with low dose intra-arterial eptifibatide and intravenous aspirin during carotid stenting: A case series.
Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Endovascular Procedures; Eptifibatide; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Stroke; Treatment Outcome | 2021 |
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
Topics: Aged; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Percutaneous Coronary Intervention; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Stroke; Sweden; Ticagrelor; Treatment Outcome | 2021 |
Administration of Ticagrelor and Double-Dose Clopidogrel Based on Platelet Reactivity Determined by VerifyNow-P2Y12 for Chinese Subjects After Elective PCI.
Topics: Adenosine; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Thrombosis; Ticagrelor; Ticlopidine | 2017 |
A retrospective comparison between delayed and early hip fracture surgery in patients taking clopidogrel: same total bleeding but different timing of blood transfusion.
Topics: Aged; Aged, 80 and over; Blood Transfusion; Clopidogrel; Female; Fracture Fixation, Internal; Hemiarthroplasty; Hemorrhage; Hip Fractures; Hip Joint; Hospital Mortality; Humans; Length of Stay; Male; Perioperative Period; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Time Factors; Time-to-Treatment; Withholding Treatment | 2017 |
Poor prognosis after surgery for intertrochanteric fracture in elderly patients with clopidogrel treatment: A cohort study.
Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Cardiovascular Diseases; China; Clopidogrel; Cohort Studies; Female; Fracture Fixation, Intramedullary; Hip Fractures; Humans; Intraoperative Complications; Length of Stay; Male; Operative Time; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Treatment Outcome | 2017 |
Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy.
Topics: Adult; Appendectomy; Appendicitis; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Female; Fibrinolytic Agents; Humans; Laparoscopy; Length of Stay; Male; Middle Aged; Patient Readmission; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Surgical Wound Infection; Ticlopidine; Treatment Outcome; United States | 2017 |
Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel.
Topics: Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Aggregation Inhibitors; Pneumonectomy; Postoperative Complications; Retrospective Studies; Ticlopidine; Treatment Outcome | 2017 |
European guidelines on perioperative venous thromboembolism prophylaxis: Chronic treatments with antiplatelet agents.
Topics: Anesthesiology; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; European Union; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Incidence; Intermittent Pneumatic Compression Devices; Long-Term Care; Nerve Block; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Risk Factors; Societies, Medical; Surgical Procedures, Operative; Time Factors; Venous Thromboembolism | 2018 |
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Guideline Adherence; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Stents; Stroke; Thrombosis; Vitamin K | 2018 |
Unplanned readmission following transoral robotic surgery.
Topics: Carcinoma, Squamous Cell; Clopidogrel; Dehydration; Female; Humans; Male; Middle Aged; Mouth; Mouth Neoplasms; Oral Hemorrhage; Pain, Postoperative; Patient Readmission; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Robotic Surgical Procedures; Ticlopidine | 2017 |
Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Cytochrome P-450 CYP2C19; DNA; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Postoperative Complications; Prasugrel Hydrochloride; Retrospective Studies; Stroke; Ticlopidine | 2018 |
Which Antiplatelet Therapy in Patients With Left Ventricular Assist Device and Aspirin Allergy?
Topics: Aspirin; Clopidogrel; Drug Hypersensitivity; Drug Therapy, Combination; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine; Warfarin | 2018 |
Treatment of Unruptured, Saccular, Anterior Choroidal Artery Aneurysms with Flow Diversion : A Single Centre Experience.
Topics: Adult; Aged; Aspirin; Cerebral Arteries; Clopidogrel; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Retrospective Studies; Vascular Patency | 2019 |
Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies.
Topics: Anticoagulants; Aspirin; Clopidogrel; Defibrillators, Implantable; Female; Hematoma; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Implantation; Retrospective Studies; Risk Factors; Warfarin | 2018 |
Neck haematoma after carotid endarterectomy: risks, rescue, and prevention.
Topics: Aged; Aged, 80 and over; Clopidogrel; Endarterectomy, Carotid; Endpoint Determination; Female; Hematoma; Heparin Antagonists; Humans; Laryngeal Masks; Male; Middle Aged; Neck Injuries; Patient Positioning; Platelet Aggregation Inhibitors; Postoperative Complications; Protamines; Reoperation; Retrospective Studies; Stroke | 2019 |
Pipeline embolization of posterior circulation aneurysms: a multicenter study of 131 aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Intracranial Aneurysm; Magnetic Resonance Angiography; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2018 |
Potent effect of prasugrel on acute phase resolution of intra-stent athero-thrombotic burden after percutaneous intervention to acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Prospective Studies; Registries; Stents; Thrombosis; Tomography, Optical Coherence; Treatment Outcome | 2018 |
Association between high on-treatment platelet reactivity to clopidogrel and hepatosteatosis in patients undergoing elective stent implantation.
Topics: Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Fatty Liver; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Preoperative Period; Prospective Studies; Stents; Ticlopidine; Treatment Outcome | 2018 |
Clopidogrel-associated genetic variants on inhibition of platelet activity and clinical outcome for acute coronary syndrome patients.
Topics: Acute Coronary Syndrome; Aged; Aryldialkylphosphatase; Aspirin; Biotransformation; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Activation; Postoperative Complications; Recurrence; Treatment Outcome | 2019 |
Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Colitis, Ulcerative; Coronary Thrombosis; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticagrelor | 2018 |
Low-Dose Prasugrel vs Clopidogrel-Based Tailored Premedication for Endovascular Treatment of Cerebral Aneurysms.
Topics: Aged; Clopidogrel; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Premedication; Retrospective Studies; Thromboembolism | 2019 |
Patients Prescribed Direct-Acting Oral Anticoagulants Have Low Risk of Postpolypectomy Complications.
Topics: Aged; Anticoagulants; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Endoscopic Mucosal Resection; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Stroke; Warfarin | 2019 |
Impact of On-Clopidogrel Platelet Reactivity on Incidence of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aortic Valve; Clopidogrel; Drug Resistance; Female; Germany; Humans; Incidence; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Protective Factors; Risk Assessment; Risk Factors; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2019 |
Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention.
Topics: Aged; Clopidogrel; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Prasugrel Hydrochloride; Republic of Korea; Thromboembolism; Ticagrelor | 2019 |
The Impact of Preoperative Clopidogrel on Outcomes After Coronary Artery Bypass Grafting.
Topics: Aged; Blood Transfusion; Clopidogrel; Cohort Studies; Coronary Artery Bypass; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Readmission; Platelet Aggregation Inhibitors; Postoperative Complications; Reoperation; Survival Rate; Treatment Outcome | 2019 |
The impact of
Topics: Aged; Alleles; Aspirin; Clopidogrel; Cytochrome P450 Family 4; Female; Genotype; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticagrelor | 2019 |
Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry.
Topics: Acute Coronary Syndrome; Aged; Cause of Death; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Registries; Retrospective Studies; Survival Rate; Ticagrelor; Treatment Outcome; United States | 2019 |
Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; China; Clopidogrel; Cross-Sectional Studies; Defibrillators, Implantable; Drug Therapy, Combination; Female; Hematoma; Heparin; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Thrombocytopenia; Ticlopidine; Warfarin | 2013 |
Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties.
Topics: Aged; Aged, 80 and over; Blood Transfusion; Clopidogrel; Comorbidity; Databases, Factual; Female; Hemiarthroplasty; Hemorrhage; Hip Fractures; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome | 2013 |
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Humans; Incidence; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Registries; Risk Factors; Ticlopidine; Treatment Outcome | 2013 |
Long-term effect of dual antiplatelet treatment after off-pump coronary artery bypass grafting.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Coronary Artery Bypass, Off-Pump; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Patient Readmission; Platelet Aggregation Inhibitors; Postoperative Complications; Prognosis; Retrospective Studies; Ticlopidine; Time Factors | 2013 |
Clopidogrel reduces post-transplant obliterative bronchiolitis.
Topics: Animals; Blood Platelets; Bronchiolitis Obliterans; Calcineurin Inhibitors; Clopidogrel; Cytokines; Everolimus; Gene Expression Regulation; Immunohistochemistry; Isoantibodies; Lung Diseases; Lung Transplantation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Microscopy, Fluorescence; Models, Animal; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; T-Lymphocytes; Tacrolimus; Ticlopidine; Time Factors; TOR Serine-Threonine Kinases; Trachea | 2013 |
A comparative study of bivalirudin plus clopidogrel versus bivalirudin plus prasugrel in primary angioplasty using propensity score matching.
Topics: Angioplasty; Antithrombins; Clopidogrel; Cohort Studies; Drug Combinations; Female; Hirudins; Humans; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Piperazines; Postoperative Complications; Prasugrel Hydrochloride; Recombinant Proteins; Retrospective Studies; Thiophenes; Thrombosis; Ticlopidine | 2013 |
Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Alleles; Aryl Hydrocarbon Hydroxylases; Biotransformation; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Substitution; Female; Genetic Testing; Genotype; Health Personnel; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenetics; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Sequence Deletion; Thiophenes; Ticlopidine | 2013 |
Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study.
Topics: Aspirin; Blood Loss, Surgical; Case-Control Studies; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prognosis; Retrospective Studies; Risk; Risk Factors; Survival Rate; Ticlopidine; Time Factors | 2014 |
A cautionary tale on the use of antiplatelet treatment following TURP.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hematuria; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine; Transurethral Resection of Prostate; Urinary Bladder; Urinary Bladder Diseases | 2014 |
The roles and issues of P2Y12 percent inhibition assessed by VerifyNow assay for patients undergoing Neurointervention: a prospective study.
Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome | 2014 |
An atypical presentation of an extremely late stent thrombosis after more than 7 years (2634 days) of DES implantation in a patient without obvious risk factors on regular dual antiplatelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine; Time Factors | 2014 |
Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery.
Topics: Aged; Case-Control Studies; Clopidogrel; Erythrocyte Transfusion; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Reoperation; Risk Factors; Thrombelastography; Ticlopidine; Treatment Outcome | 2014 |
In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
Topics: Acute Disease; Age Factors; Aged; Clopidogrel; Drug Substitution; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Postoperative Complications; Practice Guidelines as Topic; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Recurrence; Registries; Risk Factors; Thiophenes; Thrombosis; Ticlopidine; United States | 2014 |
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Comorbidity; Coumarins; Diabetes Mellitus; Female; Humans; Hypertension; Kidney Calculi; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Prevalence; Prospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urolithiasis; Young Adult | 2015 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2014 |
Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy.
Topics: Adult; Aged; Aspirin; Cardiovascular Diseases; Clopidogrel; Female; Humans; Italy; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2015 |
Should clopidogrel be discontinued before laparoscopic cholecystectomy?
Topics: Adult; Aged; Aged, 80 and over; Blood Loss, Surgical; Cholecystectomy, Laparoscopic; Clopidogrel; Female; Humans; Length of Stay; Male; Middle Aged; Morbidity; Operative Time; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Treatment Outcome | 2014 |
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Decision Support Techniques; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Markov Chains; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Adjustment; Risk Assessment; Thrombosis; Ticlopidine; Time; Treatment Outcome | 2015 |
Stent selection and antiplatelet therapy duration: one size does not fit all.
Topics: Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Postoperative Complications; Sirolimus; Ticlopidine | 2015 |
Effects of anticoagulants on outcome of femoral neck fracture surgery.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Femoral Neck Fractures; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Ticlopidine; Warfarin | 2015 |
Uninterrupted perioperative clopidogrel and bleeding-related events after total joint arthroplasty: a case series.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2015 |
Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Australia; Clopidogrel; Female; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Registries; Ticlopidine; Treatment Outcome | 2015 |
Perioperative Management of Antiplatelets and Anticoagulants Among Patients Undergoing Elective Transurethral Resection of the Prostate--A Single Institution Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Elective Surgical Procedures; Enoxaparin; Hemorrhage; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Prostate; Prostatic Hyperplasia; Retrospective Studies; Thromboembolism; Ticlopidine; Transurethral Resection of Prostate; Victoria; Warfarin; Withholding Treatment | 2015 |
[The ISAR-SAFE study].
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Administration Schedule; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Research Design; Risk; Thrombosis; Ticlopidine | 2015 |
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Female; Genotype; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Smoking; Stents; Thrombophilia; Ticlopidine; Vasodilation | 2015 |
Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Risk; Subarachnoid Hemorrhage; Thrombosis; Ticlopidine; Vitamin K | 2015 |
Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up.
Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Echocardiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Plasminogen Activator Inhibitor 1; Postoperative Complications; Prospective Studies; Risk Factors; Thrombosis; Ticlopidine; Treatment Outcome; von Willebrand Factor | 2015 |
Accumetrics-based clopidogrel dosing in endovascular neurosurgery.
Topics: Aged; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Endovascular Procedures; Female; Humans; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Thromboembolism; Ticlopidine; Treatment Outcome | 2015 |
Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
Topics: Absorbable Implants; Adult; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Design; ST Elevation Myocardial Infarction; Ticlopidine; Tissue Scaffolds; Withholding Treatment | 2017 |
It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent.
Topics: Adult; Aged; Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Registries; Sirolimus; Tetrazoles; Thrombosis; Ticlopidine; Treatment Outcome | 2015 |
Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement.
Topics: Adult; Aged; Aspirin; Clopidogrel; Drug Resistance; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Stents; Thromboembolism; Ticlopidine | 2016 |
Cochlear Implantation in the Setting of Perioperative Anticoagulation and Antiplatelet Therapy.
Topics: Aged; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Cochlear Implantation; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Warfarin | 2016 |
Late Major Hemoptysis After Lung Volume Reduction With Coils Induced by Dual Antiaggregation Therapy.
Topics: Aspirin; Clopidogrel; Hemoptysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pneumonectomy; Postoperative Complications; Pulmonary Emphysema; Severity of Illness Index; Ticlopidine; Time Factors | 2016 |
Decision making on timing of surgery for hip fracture patients on clopidogrel.
Topics: Aged, 80 and over; Blood Transfusion; Clopidogrel; Contraindications; Decision Making; Female; Hemoglobins; Hip Fractures; Humans; Length of Stay; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Hyper-Response to Clopidogrel in Japanese Patients Undergoing Transcatheter Aortic Valve Implantation.
Topics: Aged, 80 and over; Aortic Valve Stenosis; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Humans; Japan; Male; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Postoperative Complications; Prognosis; Prospective Studies; Thrombosis; Ticlopidine; Transcatheter Aortic Valve Replacement | 2016 |
Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.
Topics: Anticoagulants; Aspirin; Clopidogrel; Female; Hematoma; Humans; Male; Middle Aged; Parathyroidectomy; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Thyroidectomy; Ticlopidine | 2016 |
Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study.
Topics: Acute Coronary Syndrome; Age Factors; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Prognosis; Retrospective Studies; Risk Assessment; Sex Distribution; Sex Factors; Survival Rate; Ticlopidine; Treatment Outcome; United States | 2017 |
Complication of Stenting in Intracranial Arterial Stenosis.
Topics: Age Factors; Aged; Angioplasty; Aspirin; China; Clopidogrel; Computed Tomography Angiography; Constriction, Pathologic; Female; Follow-Up Studies; Humans; Intracranial Arteriosclerosis; Kaplan-Meier Estimate; Male; Middle Aged; Perioperative Period; Postoperative Complications; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Outcome | 2016 |
Ticagrelor for left ventricular assist device thrombosis: A new therapeutic option to be evaluated with caution.
Topics: Adenosine; Aged; Aspirin; Blood Coagulation; Cardiomyopathies; Clopidogrel; Drug Substitution; Drug Therapy, Combination; Fibrinolytic Agents; Heart-Assist Devices; Humans; Male; Medication Therapy Management; Postoperative Complications; Risk Adjustment; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome | 2016 |
Efficacy of a two-test protocol for achieving a therapeutic response to clopidogrel prior to elective endovascular intracranial aneurysm treatment and an 'induced' postoperative hyper-response.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Cohort Studies; Elective Surgical Procedures; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Retrospective Studies; Ticlopidine; Treatment Outcome | 2017 |
The Effect of Antiplatelet Agents on Bleeding-Related Complications After Ureteroscopy.
Topics: Adenosine; Adult; Aged; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Risk; Ticagrelor; Ticlopidine; Ureteroscopy | 2016 |
CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift?
Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Metoprolol; Middle Aged; Morphine; Myocardial Infarction; Nitroglycerin; Ovarian Neoplasms; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Retreatment; Ticlopidine; Treatment Outcome; Vasodilator Agents | 2016 |
Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate.
Topics: Aspirin; Cardiopulmonary Bypass; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Revascularization; North Carolina; Patient Discharge; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Postoperative Period; Prevalence; Prognosis; Survival Rate; Ticlopidine | 2016 |
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Impact of Anticoagulant and Antiplatelet Drugs on Perioperative Outcomes of Robotic-assisted Partial Nephrectomy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Morbidity; Nephrectomy; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Robotic Surgical Procedures; Ticlopidine | 2017 |
Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms.
Topics: Adult; Aged; Aspirin; Clopidogrel; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Stents; Ticlopidine; Treatment Outcome | 2017 |
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model.
Topics: Animals; Aspirin; Clopidogrel; Disease Models, Animal; Fibrinolytic Agents; Graft Survival; Heparin; Hirudins; Ischemia; Laser-Doppler Flowmetry; Male; Microcirculation; Pentoxifylline; Postoperative Complications; Rats; Rats, Wistar; Skin Diseases; Skin Transplantation; Surgical Flaps; Ticlopidine | 2016 |
Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Cause of Death; Clopidogrel; Diabetic Angiopathies; Drug Therapy, Combination; Drug Utilization; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Proportional Hazards Models; Stroke; Survival Rate; Ticlopidine | 2017 |
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Postoperative Complications; Sequence Analysis, DNA; Stents; Thrombosis; Ticlopidine; Treatment Outcome; Turkey | 2017 |
Reversible thrombotic mitral valve stenosis after transcatheter mitral valve replacement (TMVR): Is life-long anticoagulation therapy necessary?
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Cardiac Catheterization; Clopidogrel; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Mitral Valve; Mitral Valve Stenosis; Postoperative Complications; Thrombosis; Ticlopidine; Treatment Outcome; Warfarin | 2017 |
Clopidogrel therapy--implications for hip fracture surgery.
Topics: Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Drug Administration Schedule; Follow-Up Studies; Hemoglobins; Hip Fractures; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Time Factors | 2008 |
Very late stent thrombosis after discontinuation of clopidogrel therapy.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Failure; Radiography; Stents; Ticlopidine; Time Factors | 2008 |
Survival benefit with concomitant oral platelet therapy after coronary angiography and before ad hoc percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Severity of Illness Index; Survival Analysis; Ticlopidine; Treatment Outcome | 2008 |
Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Severity of Illness Index; Survival Analysis; Ticlopidine; Treatment Outcome | 2008 |
Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine.
Topics: Administration, Oral; Animals; Aspirin; Bioprosthesis; Clopidogrel; Dalteparin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Valve Prosthesis Implantation; Injections, Subcutaneous; Postoperative Care; Postoperative Complications; Random Allocation; Risk Factors; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Swine; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Time Factors | 2008 |
[Management of a high risk of thrombosis patient with drug-eluting stents undergoing a complete gastrectomy].
Topics: Aged; Clopidogrel; Drug-Eluting Stents; Gastrectomy; Humans; Male; Monitoring, Physiologic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Stomach Neoplasms; Thrombosis; Ticlopidine | 2009 |
Post-treatment platelet reactivity predicts long-term adverse events better than the response to clopidogrel in patients with non-ST-segment elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Artery Bypass; Electrocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Predictive Value of Tests; Prognosis; Ticlopidine; Treatment Outcome | 2009 |
[Do antiplatelet agents (aspirin and other antiplatelets such as clopidogrel) increase the risk of hemorrhagic complications after endoscopic polypectomy or endoscopic sphincterotomy and should these drugs therefore be withdrawn 7-10 days before these pro
Topics: Aspirin; Clopidogrel; Colonic Polyps; Colonoscopy; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Preoperative Care; Risk Factors; Sphincterotomy, Endoscopic; Ticlopidine; Time Factors | 2009 |
Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
Topics: Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Thrombosis; Ticlopidine; Time Factors | 2009 |
[Percutaneous endoscopic gastrostomy. Complications with and without anticoagulation].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Child; Child, Preschool; Clopidogrel; Contraindications; Drug Therapy, Combination; Female; Gastrostomy; Heparin, Low-Molecular-Weight; Humans; Infant; Male; Middle Aged; Multivariate Analysis; Peritonitis; Pilot Projects; Postoperative Complications; Postoperative Hemorrhage; Prognosis; Prospective Studies; Risk Factors; Surgical Wound Infection; Thromboembolism; Ticlopidine | 2010 |
Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Brain Ischemia; Cerebral Arteries; Clopidogrel; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Retrospective Studies; Stents; Stroke; Thrombectomy; Ticlopidine; Treatment Outcome; Vascular Surgical Procedures | 2009 |
Potential unrecognised costs of clopidogrel pretreatment in acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; American Heart Association; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Costs and Cost Analysis; Female; Guideline Adherence; Humans; Length of Stay; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Retrospective Studies; Ticlopidine; Time Factors; United States | 2009 |
Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting.
Topics: Adult; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Ticlopidine | 2009 |
[Antiplatelet therapy and urgent surgical procedures. Acute appendicitis two days after stent implantation--a case report].
Topics: Appendicitis; Clopidogrel; Coronary Thrombosis; Dobutamine; Humans; Intraoperative Complications; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Reoperation; Stents; Ticlopidine | 2009 |
Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery.
Topics: Analysis of Variance; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Treatment; Female; Follow-Up Studies; Hospital Mortality; Humans; Logistic Models; Male; Multivariate Analysis; Postoperative Complications; Postoperative Hemorrhage; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Ticlopidine | 2010 |
Safety of carotid endarterectomy while on clopidogrel (Plavix). Clinical article.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Edema; Endarterectomy, Carotid; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Postoperative Complications; Prothrombin Time; Retrospective Studies; Risk; Stroke; Ticlopidine | 2010 |
Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Dermatologic Surgical Procedures; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythema; Female; Follow-Up Studies; Hematoma; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Surgical Wound Dehiscence; Surgical Wound Infection; Ticlopidine; Warfarin | 2010 |
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
Topics: Aged; Analgesia, Epidural; Clopidogrel; Female; Hematoma, Epidural, Spinal; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Vascular Surgical Procedures | 2010 |
Letter by Doraiswamy regarding article, "Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring
Topics: Anticoagulants; Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Double-Blind Method; Drug Resistance; Elective Surgical Procedures; Hemorrhage; Heparin; Humans; Myocardial Revascularization; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Research Design; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine | 2010 |
[Comment about patients with dual antiplatelet therapy].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Contraindications; Drug Therapy, Combination; Elective Surgical Procedures; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Preoperative Care; Thromboembolism; Ticlopidine | 2010 |
The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Topics: Aged; Amlodipine; Angioplasty; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platelets; Calcium Channel Blockers; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Ticlopidine | 2010 |
I had two stents put in during the past year, but I'm going to have a hip replacement soon. Are there any heart-related or stent related precautions my doctor and I should take before the surgery?
Topics: Angioplasty, Balloon, Coronary; Arthroplasty, Replacement, Hip; Aspirin; Clopidogrel; Drug-Eluting Stents; Health Knowledge, Attitudes, Practice; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Stents; Ticlopidine | 2009 |
Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care.
Topics: Cardiovascular Diseases; Chemotherapy, Adjuvant; Clopidogrel; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Medication Therapy Management; Myocardial Infarction; Patient Compliance; Patient Discharge; Platelet Aggregation Inhibitors; Postoperative Complications; Prescriptions; Prosthesis Implantation; Retrospective Studies; Risk Factors; Survival Analysis; Ticlopidine; United States | 2010 |
Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Chemical and Drug Induced Liver Injury; Clopidogrel; Female; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine | 2010 |
Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events: post-operative transcranial Doppler monitoring is now unnecessary.
Topics: Aged; Angioscopy; Anticoagulants; Aspirin; Clopidogrel; Dextrans; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Fibrinolytic Agents; Humans; Male; Medical Audit; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Retrospective Studies; Thromboembolism; Ticlopidine; Ultrasonography, Doppler, Transcranial | 2010 |
The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Clopidogrel; Cohort Studies; Contraindications; Female; Humans; Male; Orthopedic Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine | 2010 |
Clinical pharmacology: antiplatelet therapy during surgery.
Topics: Aspirin; Blood Loss, Surgical; Clopidogrel; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine | 2010 |
The evidence base for platelet function testing in patients undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Atherectomy; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Diagnostic Tests, Routine; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Implantation; Ticlopidine | 2010 |
Routine platelet testing should not be performed on all patients undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Atherectomy; Blood Platelets; Clopidogrel; Diagnostic Tests, Routine; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Practice Guidelines as Topic; Precision Medicine; Reference Standards; Reference Values; Research Design; Thrombosis; Ticlopidine | 2010 |
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
Topics: Analgesia, Epidural; Clopidogrel; Hematoma, Epidural, Spinal; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Ticlopidine; Vascular Surgical Procedures | 2010 |
Epidural analgesia in vascular surgery patients actively taking clopidogrel.
Topics: Analgesia, Epidural; Clopidogrel; Hematoma, Epidural, Spinal; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Vascular Surgical Procedures | 2010 |
Frequency and risk of noncardiac surgery after drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Assessment; Risk Factors; Surgical Procedures, Operative; Texas; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms?
Topics: Aneurysm, Ruptured; Clopidogrel; Embolization, Therapeutic; Female; Humans; Incidence; Intracranial Aneurysm; Intracranial Thrombosis; Korea; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Premedication; Prevalence; Risk Assessment; Risk Factors; Ticlopidine | 2010 |
Comparison of hemorrhagic complications of warfarin and clopidogrel bisulfate in 25-gauge vitrectomy versus a control group.
Topics: Aged; Anticoagulants; Cardiovascular Diseases; Choroid Hemorrhage; Clopidogrel; Humans; Incidence; Intraocular Pressure; Intraoperative Complications; Microsurgery; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retinal Diseases; Retrobulbar Hemorrhage; Retrospective Studies; Risk Factors; Ticlopidine; Visual Acuity; Vitrectomy; Vitreous Hemorrhage; Warfarin | 2011 |
Upper digestive bleeding due to Dieulafoy´s lesion during the postoperative period of aortocoronary bypass surgery in a patient treated with clopidogrel.
Topics: Aged; Arterioles; Clopidogrel; Coronary Artery Bypass; Gastrointestinal Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Stomach; Ticlopidine | 2010 |
Invited commentary.
Topics: Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; Drainage; Humans; Intubation, Gastrointestinal; Minimally Invasive Surgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Premedication; Sternotomy; Thrombosis; Ticlopidine | 2011 |
Immortal person-time bias in observational studies in cardiac surgery.
Topics: Aspirin; Bias; Clopidogrel; Coronary Artery Bypass; Data Interpretation, Statistical; Drug Therapy, Combination; Hemorrhage; Hospital Mortality; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Research Design; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome | 2011 |
Did clopidogrel confound the results?
Topics: Clopidogrel; Coronary Artery Bypass, Off-Pump; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Stroke; Ticlopidine | 2011 |
Does hemodialysis affect clopidogrel resistance as measured by VerifyNow P2Y12 test?
Topics: Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Drug Resistance; Humans; Kidney Failure, Chronic; Long-Term Care; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Renal Dialysis; Stents; Ticlopidine; Treatment Outcome | 2011 |
Very late thrombosis of flow-diverting constructs after the treatment of large fusiform posterior circulation aneurysms.
Topics: Adult; Cerebral Angiography; Cerebral Revascularization; Cerebrovascular Circulation; Clopidogrel; Fatal Outcome; Female; Humans; Intracranial Aneurysm; Male; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombectomy; Thrombosis; Ticlopidine; Time Factors | 2011 |
[Preoperative analysis of platelet aggregability in carotid surgery].
Topics: Aged; Aged, 80 and over; Aspirin; Carotid Arteries; Clopidogrel; Endarterectomy, Carotid; Female; Humans; Intraoperative Complications; Ischemia; Male; Middle Aged; Perioperative Period; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Ticlopidine | 2011 |
Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Dermatologic Surgical Procedures; Female; Humans; Male; Middle Aged; Mohs Surgery; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Ticlopidine; Warfarin | 2011 |
The impact of noncardiac surgery on selection of a revascularization strategy.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Drug-Eluting Stents; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Risk Factors; Surgical Procedures, Operative; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Loss, Surgical; Clopidogrel; Drug Therapy, Combination; Eye Hemorrhage; Female; Humans; Intraoperative Complications; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Prothrombin Time; Risk Assessment; Thromboembolism; Ticlopidine; Warfarin | 2011 |
Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications.
Topics: Aged; Ambulatory Surgical Procedures; Antibiotic Prophylaxis; Anticoagulants; Clopidogrel; Dermatologic Surgical Procedures; Female; Humans; Male; Mohs Surgery; Necrosis; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Surgical Flaps; Surgical Wound Infection; Ticlopidine; Warfarin | 2011 |
Emergency surgery following trancutaneous aortic valve insertion.
Topics: Aged, 80 and over; Aortic Valve; Aspirin; Blood Loss, Surgical; Clopidogrel; Emergency Medical Services; Femoral Neck Fractures; Heart Valve Prosthesis Implantation; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2011 |
Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Topics: Anticoagulants; Aspirin; Clopidogrel; Diabetic Retinopathy; Female; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Hemorrhage; Warfarin | 2011 |
Clopidogrel: is a surgical delay necessary in fractured neck of femur?
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Clopidogrel; Dipyridamole; Female; Femoral Neck Fractures; Hemoglobins; Humans; Length of Stay; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Thrombus formation on a left atrial appendage closure device.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design; Heart Diseases; Heparin; Humans; Male; Postoperative Complications; Septal Occluder Device; Thrombophilia; Thrombosis; Ticlopidine; Ultrasonography | 2011 |
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Hematoma, Subdural, Acute; Hematoma, Subdural, Chronic; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Remission Induction; Risk Factors; Ticlopidine; Withholding Treatment | 2012 |
On-clopidogrel platelet reactivity: a target in sight?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2011 |
The safety of major head and neck surgery in patients taking clopidogrel (Plavix).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Thrombosis; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Young Adult | 2012 |
Use of an objective tool to assess platelet inhibition prior to off-pump coronary surgery to reduce blood usage.
Topics: Adenosine Diphosphate; Aged; Blood Coagulation Tests; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass, Off-Pump; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Reoperation; Ticlopidine | 2012 |
Successful use of glycoprotein IIb/IIIa inhibitor, heparin, and IABP during PCI in a post-neurosurgical patient with STEMI and cardiogenic shock due to very late bare-metal stent thrombosis.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Heparin; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Shock, Cardiogenic; Spinal Fusion; Stents; Thrombosis; Ticlopidine | 2012 |
Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Local; Anesthetics, Local; Anticoagulants; Aspirin; Bupivacaine; Clopidogrel; Conjunctiva; Female; Humans; Intraoperative Complications; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Suture Techniques; Ticlopidine; Treatment Outcome; Visual Acuity; Vitrectomy; Warfarin | 2012 |
No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Vessels; DNA Mutational Analysis; Drug-Eluting Stents; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Postoperative Complications; Risk; Thrombosis; Ticlopidine | 2012 |
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prospective Studies; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Warfarin | 2012 |
Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Animals; Clinical Protocols; Clopidogrel; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Risk Factors; Ticlopidine | 2012 |
Utility of VasoCT in the treatment of intracranial aneurysm with flow-diverter stents.
Topics: Adult; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Aspirin; Catheterization; Cerebral Angiography; Cerebral Arteries; Clopidogrel; Female; Fluoroscopy; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Intracranial Aneurysm; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Tomography, X-Ray Computed | 2012 |
Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting.
Topics: Aged; Aspirin; Blood Transfusion; Chi-Square Distribution; Clopidogrel; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Reoperation; Retrospective Studies; Statistics, Nonparametric; Ticlopidine; United Kingdom | 2013 |
Perioperative management of a neurosurgical patient requiring antiplatelet therapy.
Topics: Aged; Aspirin; Cerebral Angiography; Clopidogrel; Humans; Intracranial Aneurysm; Intracranial Thrombosis; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Neurologic Examination; Neurosurgical Procedures; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Tomography, X-Ray Computed; Ventriculoperitoneal Shunt | 2012 |
Successful resection of complicated bleeding arteriovenous malformation of the jejunum in patients starting dual-antiplatelet therapy just after implanting a drug-eluting coronary stent.
Topics: Arteriovenous Malformations; Aspirin; Clopidogrel; Drug-Eluting Stents; Gastrointestinal Hemorrhage; Humans; Jejunum; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2012 |
Continued concern about parent vessel steno-occlusive progression with Onyx HD-500 and the utility of quantitative magnetic resonance imaging in serial assessment.
Topics: Angioplasty; Aspirin; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Constriction, Pathologic; Databases, Factual; Disease Progression; Embolization, Therapeutic; Humans; Intracranial Aneurysm; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome | 2013 |
Friend or foe? Discussion about dual platelet inhibition as a salvage procedure from imminent flap failure.
Topics: Aspirin; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mammaplasty; Middle Aged; No-Reflow Phenomenon; Platelet Aggregation Inhibitors; Postoperative Complications; Salvage Therapy; Surgical Flaps; Ticlopidine | 2013 |
Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section.
Topics: Aspirin; Cerebral Angiography; Cesarean Section; Clopidogrel; Female; Headache; Humans; Magnetic Resonance Imaging; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Syndrome; Ticlopidine; Tomography, X-Ray Computed; Vasoconstriction; Vasospasm, Intracranial; Vertebral Artery Dissection | 2013 |
[Long-term anticoagulation after bypass operation].
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Long-Term Care; Platelet Aggregation Inhibitors; Postoperative Complications; Recurrence; Ticlopidine | 2002 |
New antiplatelet agents and prosthetic heart valves.
Topics: Abciximab; Aged; Antibodies, Monoclonal; Clopidogrel; Female; Heart Valve Prosthesis Implantation; Humans; Immunoglobulin Fab Fragments; Infant; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Thromboembolism; Ticlopidine | 2002 |
Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy.
Topics: Aged; Anticoagulants; Aspirin; Carcinoma, Basal Cell; Clopidogrel; Drug Administration Schedule; Female; Heparin, Low-Molecular-Weight; Humans; Mohs Surgery; Nose Neoplasms; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Skin Neoplasms; Ticlopidine; Venous Thrombosis | 2002 |
Clopidogrel versus ticlopidine after the placement of coronary artery stents.
Topics: Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome | 2003 |
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Cerebrovascular Disorders; Clopidogrel; Coronary Angiography; Coronary Disease; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Septal Defects, Atrial; Heart Valve Diseases; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin | 2003 |
Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.
Topics: Aged; Anticoagulants; Clopidogrel; Colonic Polyps; Colonoscopy; Female; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine; Warfarin | 2004 |
Are we making efficient use of clopidogrel?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2004 |
If there's smoke, is there fire?
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Endpoint Determination; Humans; Intracranial Embolism; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Research Design; Ticlopidine; Ultrasonography, Doppler, Transcranial | 2004 |
Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Humans; Isoenzymes; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Troponin I | 2004 |
Multivessel distal sutureless off-pump coronary artery bypass grafting procedure using magnetic connectors.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Restenosis; Coronary Stenosis; Equipment Design; Humans; Internal Mammary-Coronary Artery Anastomosis; Magnetics; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine | 2004 |
Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Creatine Kinase; Creatine Kinase, MB Form; Disease-Free Survival; Equipment Design; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Isoenzymes; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; New York; Platelet Aggregation Inhibitors; Postoperative Complications; Severity of Illness Index; Stents; Ticlopidine; Treatment Outcome; Troponin I | 2004 |
Does clopidogrel increase blood loss following coronary artery bypass surgery?
Topics: Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Critical Care; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Emergencies; Female; Humans; Intensive Care Units; Length of Stay; London; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Premedication; Prospective Studies; Risk Factors; Ticlopidine | 2004 |
Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Premedication; Prospective Studies; Reoperation; Risk Factors; Thrombosis; Ticlopidine | 2005 |
Effects of clopidogrel and high dose aspirin on survival of skin flaps in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Rats; Rats, Wistar; Surgical Flaps; Ticlopidine; Tissue Survival | 2005 |
Technique of left main stenting is dependent on lesion location and distal branch protection.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; North Carolina; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Stroke Volume; Ticlopidine; Treatment Outcome | 2005 |
The value of clopidogrel administered postoperatively following a non-ST-segment elevation acute coronary syndrome.
Topics: Clopidogrel; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Postoperative Complications; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Ticlopidine; Treatment Outcome | 2005 |
Intense migraines secondary to percutaneous closure of atrial septal defects.
Topics: Adult; Cardiac Catheterization; Clopidogrel; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Septal Defects, Atrial; Humans; Male; Migraine without Aura; Minimally Invasive Surgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome | 2005 |
Intracranial bleeding associated with clopidogrel.
Topics: Aged; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Clopidogrel; Coronary Stenosis; Humans; Hypertension; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Tomography, X-Ray Computed | 2005 |
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septal Defects, Atrial; Humans; Male; Medical Audit; Middle Aged; Migraine with Aura; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Complications; Ticlopidine | 2005 |
Economic effects of extended clopidogrel therapy--a word of caution.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2005 |
Treatment of wide-necked intracranial aneurysms with a self-expanding stent: mid-term results.
Topics: Aneurysm, Ruptured; Clopidogrel; Follow-Up Studies; Humans; Intracranial Aneurysm; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Subarachnoid Hemorrhage; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Venous thromboembolism and fractured neck of femur.
Topics: Aged; Aged, 80 and over; Anesthesia; Anticoagulants; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Female; Femoral Neck Fractures; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Patient Readmission; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Sex Distribution; Ticlopidine; Treatment Outcome; Venous Thrombosis | 2005 |
Clopidogrel-aspirin inhibit the thrombogenicity of St. Jude mechanical aortic prostheses.
Topics: Aspirin; Clopidogrel; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Thromboembolism; Ticlopidine | 2006 |
[Postoperative antithrombotic treatment in diabetic patients].
Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Thrombosis; Ticlopidine; Warfarin | 2006 |
Impact of PlA polymorphism of platelet GP IIb/IIIa receptors on clinical course during long-term LVAD support is independent of type of LVAD.
Topics: Anticoagulants; Antigens, Human Platelet; Aspirin; Clopidogrel; Equipment Design; Genetic Predisposition to Disease; Genotype; Heart-Assist Devices; Hemorrhagic Disorders; Humans; Incidence; Integrin beta3; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Postoperative Complications; Thromboembolism; Thrombophilia; Ticlopidine | 2006 |
Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
Topics: Aged; Aged, 80 and over; Antithrombin III; Arterial Occlusive Diseases; Aspirin; Blood Coagulation; Clopidogrel; Female; Fibrin Fibrinogen Degradation Products; Humans; Ischemia; Male; P-Selectin; Peptide Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Reperfusion; Thrombosis; Ticlopidine; Vascular Surgical Procedures; von Willebrand Factor | 2006 |
Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stents.
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Vessels; Delayed-Action Preparations; Humans; Paclitaxel; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Stents; Ticlopidine | 2006 |
Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Injections, Intravenous; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Tirofiban; Tyrosine | 2007 |
Operative delay for orthopedic patients on clopidogrel (plavix): a complete lack of consensus.
Topics: Adult; Clopidogrel; Emergency Treatment; Female; Fracture Fixation, Internal; Health Care Surveys; Hip Fractures; Humans; Internship and Residency; Male; Needs Assessment; Orthopedics; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Practice Patterns, Physicians'; Prognosis; Risk Assessment; Surveys and Questionnaires; Ticlopidine; Time Factors | 2008 |
[Antithrombotic therapy in operations on extracranial arteries].
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Endarterectomy, Carotid; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Postoperative Complications; Russia; Ticlopidine | 2008 |
Studies published on clopidogrel-aspirin for coronary stent placement.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine | 2000 |
Clopidogrel instead of ticlopidine after coronary stent placement: is the switch justified?
Topics: Clopidogrel; Coronary Artery Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Thrombosis; Ticlopidine | 2000 |
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Disease; Cost-Benefit Analysis; Drug Costs; Equipment Design; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Stents; Ticlopidine | 2000 |
[Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery].
Topics: Aspirin; Clopidogrel; Coronary Disease; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2001 |
Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Implantation; Stents; Ticlopidine | 2001 |
Treatment of acute coronary syndromes.
Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine | 2002 |
OPCAB therapy survey: off-pump clopidogrel, aspirin or both therapy survey.
Topics: Anticoagulants; Aspirin; Canada; Cardiology; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Data Collection; Drug Therapy, Combination; Humans; Intraoperative Complications; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; United States | 2001 |
[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
Topics: Anticholesteremic Agents; Anuria; Clopidogrel; Coronary Artery Bypass; Humans; Hypercholesterolemia; Intracranial Thrombosis; Male; Middle Aged; Muscle Weakness; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Pyridines; Rhabdomyolysis; Ticlopidine | 2001 |